The effect of long-lasting insecticidal nets on the transmission of malaria and lymphatic filariasis in Papua New Guinea, and opportunities for accelerating lymphatic filariasis elimination through novel treatment strategies by Thomsen, Edward K.
warwick.ac.uk/lib-publications   
 
 
 
 
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/129916 
 
 
 
Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
The effect of long-lasting insecticidal nets on the 
transmission of malaria and lymphatic filariasis in 
Papua New Guinea, and opportunities for 
accelerating lymphatic filariasis elimination 
through novel treatment strategies 
 
 
 
By 
Edward Kendall Thomsen 
 
 
 
A thesis submitted in partial fulfilment of the requirements for the 
degree of 
Doctor of Philosophy 
 
University of Warwick 
School of Life Sciences 
 
October 2018 
 
i 
 
 
Contents 
List of figures and tables ............................................................................ iii 
Acknowledgments ..................................................................................... iv 
Submission Declaration .............................................................................. v 
Abbreviations ........................................................................................... vi 
Summary ................................................................................................ vii 
Introduction .............................................................................................. 1 
Anopheles mosquitoes ............................................................................. 1 
Malaria transmission and epidemiology ...................................................... 1 
Lymphatic filariasis transmission and epidemiology ..................................... 2 
Control and elimination of LF and malaria .................................................. 3 
Control challenges .................................................................................. 6 
Malaria and LF in Papua New Guinea ......................................................... 8 
Hypotheses, aims, and objectives ........................................................... 11 
Summary of the studies ........................................................................... 11 
Paper 1 - Insecticidal Bed Nets and Filariasis Transmission in Papua New 
Guinea ................................................................................................ 15 
Rationale .......................................................................................... 15 
Methods ........................................................................................... 16 
Results ............................................................................................. 16 
Summary interpretation and conclusion ................................................ 18 
Paper 2 - Malaria transmission dynamics surrounding the first nationwide long-
lasting insecticidal net distribution in Papua New Guinea............................ 18 
Rationale .......................................................................................... 18 
Methods ........................................................................................... 19 
Results ............................................................................................. 20 
Summary interpretation and conclusion ................................................ 21 
ii 
 
Paper 3 - Mosquito behaviour change after distribution of bednets results in 
decreased protection against malaria exposure ........................................ 22 
Rationale .......................................................................................... 22 
Methods ........................................................................................... 22 
Results ............................................................................................. 23 
Summary interpretation and conclusion ................................................ 23 
Paper 4 - Efficacy, safety, and pharmacokinetics of co-administered 
diethylcarbamazine, albendazole, and ivermectin for treatment of Bancroftian 
filariasis............................................................................................... 25 
Rationale .......................................................................................... 25 
Methods ........................................................................................... 25 
Results ............................................................................................. 26 
Summary interpretation and conclusion ................................................ 26 
Discussion .............................................................................................. 27 
Impact of LLINs on mosquito abundance, behaviour, and composition ......... 27 
Impact of LLINs on disease transmission and prevalence ........................... 29 
Complementary, integrated control measures to increase the likelihood of LF 
elimination ........................................................................................... 30 
Significance and Impact ........................................................................... 31 
References .............................................................................................. 33 
Appendix 1. Co-author statements ............................................................. 50 
Appendix 2. Edward Thomsen full bibliography ............................................ 75 
Appendix 3. The published works ............................................................... 78 
 
  
iii 
 
List of figures and tables 
Figures 
Figure 1 Relative sizes of the developmental stages of Brugia malayi ............... 3 
Figure 2 Depiction of the worm breakpoint values at various vector biting rates 5 
Figure 3 Venn diagram showing the three major objectives of the thesis ........ 13 
Figure 4 Timeline of various activities for each paper. .................................. 14 
Figure 5 Map of Papua New Guinea ............................................................ 15 
Figure 6 Annual transmission potential (L3 inoculated per person per year) 
before LLINs (2007-2008 and 2008-2009) and after LLINs (2009-2010). ........ 17 
Figure 7 Changes in anopheline biting time following introduction of LLINs and 
nocturnal periodicity of microfilaremia ........................................................ 17 
Figure 8 Anopheline biting rates (MBR, left side) and entomological inoculation 
rate (EIR, right side) in the three study regions. .......................................... 20 
Figure 9 Total estimated exposure to bites for a non–net user before LLINs 
(2008) and after LLINs (2009-2011) in both study villages. .......................... 22 
Figure 10 The protective efficacy of LLINs ................................................... 23 
Figure 11 Human malaria prevalence ......................................................... 23 
Figure 12 Percent reduction in microfilaria levels compared to pre-treatment .. 26 
 
Tables 
Table 1 Characteristics of the five major malaria vector species in Papua New 
Guinea.....................................................................................................9 
Table 2 Characteristics of the four publications submitted as part of this 
thesis.....................................................................................................12 
  
iv 
 
Acknowledgments 
This work is the culmination of a journey spanning ten years. It was never 
intended to comprise a PhD thesis, but through a relatively circuitous path, it 
has developed into something I am proud to present as such. First, the 
formalities: this work would not have been possible without financial support 
from the National Institutes of Health and the National Science Foundation in the 
United States, the Bill & Melinda Gates Foundation, and the Global Fund to Fight 
Aids, Tuberculosis, and Malaria.  
I am sincerely grateful for the support of the faculty at the Center for Global 
Health and Diseases at Case Western Reserve University for putting their faith in 
a young entomologist eager for a scientific (and life) adventure. In particular, I 
would like to thank Prof. James Kazura and Prof. Christopher King for their sage 
advice, strong scientific leadership, and devotion to supporting my career 
development. I am also grateful to Prof. Peter Zimmerman and Will Kastens for 
introducing me to the Papua New Guinea Institute of Medical Research 
(PNGIMR). 
These studies would not have been possible without the devotion of colleagues 
at the PNGIMR, including members of the entomology unit in Madang and the 
clinical team based in Maprik. I would like to acknowledge Manasseh Baea in 
particular, whose patience and hospitality enabled me to assimilate quickly into 
PNG culture, and whose extensive experience in research management made 
these studies possible. I would also like to thank the co-authors on all the 
manuscripts presented as part of this thesis, whose expertise and input greatly 
improved the quality of these studies, and the community members in our study 
sites, who volunteered to make these studies possible.  Thank you as well goes 
to Prof. Orin Courtenay for his encouragement, support, and advice during the 
final stages of tying this work together into a cohesive story. 
Finally, my family. This work would never have happened without the 
companionship, adventurousness, and unwavering personal and professional 
support of my wife Lisa. I continue to be amazed by her dedication and 
proficiency in all endeavours scientific or familial. We moved to Papua New 
Guinea only four months after getting married, and we subsequently built an 
amazing family and fulfilling careers together.  Thank you also to my wonderful 
daughters, Evelyn and Mae, who consistently remind me of reasons to be 
grateful.  
v 
 
Submission Declaration 
This thesis is submitted to the University of Warwick in support of my application 
for the degree of Doctor of Philosophy. It has been composed by myself and has 
not been submitted in any previous application for any degree. The work 
presented (including data generated and data analysis) was carried out by the 
author except in the cases of the published works, which were collaborative. A 
statement of the author’s contribution to these works can be found in Appendix 
1.  
vi 
 
Abbreviations 
µm micrometre 
AE adverse event 
ALB albendazole 
ALT alanine transaminase 
AST aspartate transaminase 
ATP annual transmission potential 
DALY disability adjusted life year 
DDT dichlorodiphenyltrichloroethane 
DEC diethylcarbamazine 
DNA deoxyribonucleic acid 
EIR entomological inoculation rate 
ELISA enzyme-linked immunosorbent assay 
GEE generalised estimating equations 
GFATM Global Fund to Fight Aids, Tuberculosis, and Malaria 
GMEP Global Malaria Elimination Program 
GPELF Global Program to Eliminate Lymphatic Filariasis 
IDA ivermectin, diethylcarbamazine, and albendazole 
IRS indoor residual spraying 
ITN insecticide-treated net 
IVM integrated vector management 
IVM ivermectin 
km kilometre 
L3 third stage larva 
LF Lymphatic filariasis 
LLIN long-lasting insecticidal net 
MDA mass drug administration 
MF microfilaria 
mL millilitre 
NTD neglected tropical disease 
PCR polymerase chain reaction 
PNG Papua New Guinea 
TAS transmission assessment survey 
WHO World Health Organization 
 
  
vii 
 
Summary 
Currently, programmatic interventions to combat vector-borne diseases are 
largely underpinned by the concept that strategies proven effective in one 
context will work in all contexts. However, areas with high vector diversity 
present a challenge because the traits targeted by an intervention may not exist 
in most of the population. Papua New Guinea (PNG) is endemic for both malaria 
and lymphatic filariasis (LF) and has a diverse vector population. Typical vector 
control measures, such as long-lasting insecticidal nets (LLINs), have been very 
successful in reducing malaria burden in sub-Saharan Africa, partly because 
these mosquitoes bite humans at night inside houses. However, it may be that 
this intervention is inappropriate in areas like PNG, where a wide range of biting 
behaviour is the status quo, and that deploying complementary strategies will be 
necessary. The aim of this thesis is to evaluate the efficacy of existing and 
emerging interventions to prevent malaria and LF transmission and eliminate 
filariasis in PNG. This will be achieved through studies which 1) evaluate the 
impact of a nationwide LLIN distribution on vector density, behaviour, and 
species composition, 2) evaluate the impact of LLINs on malaria and LF 
transmission and disease prevalence and 3) evaluate the efficacy of 
complementary, integrated control measures to increase the likelihood of LF 
elimination. The data from observational and cross-sectional studies and a 
controlled clinical trial, demonstrate that LLINs can decrease transmission 
intensity of both malaria and LF in PNG. However, the sustainability of this 
control measure may be compromised by an epidemiologically significant shift in 
the behaviour of mosquitoes to bite at earlier hours of the night. Modifying LF 
elimination efforts, which typically include a mass administration of two drugs to 
the at-risk population, to incorporate a novel 3-drug regimen, is shown to 
potentially increase the likelihood of eliminating the disease. 
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Introduction 
Anopheles mosquitoes 
Mosquitoes in the genus Anopheles are arguably one of the most significant 
animals impacting human health. They are important vectors of human disease-
causing pathogens, transmitting malarial protozoa, filarial nematodes, and less 
frequently, arthropod-borne viruses (arboviruses). Anopheline mosquitoes are 
distributed world-wide, but the most medically important vectors occur in 
tropical and sub-tropical regions1, where higher temperatures allow relatively 
rapid development of parasitic infections. The most important vectors are closely 
associated with humans, having evolved search patterns targeting human-
associated olfactory2 and visual3 cues. Understanding this behaviour has led to 
the development of the widespread vector control interventions long-lasting 
insecticidal nets (LLINs) and indoor residual spraying (IRS), which exploit the 
tendency of these mosquitoes to seek out humans for a blood meal.   
However, of the 41 different species of anophelines that transmit malaria1, 
relatively few are completely anthropophilic. There is significant variation in 
host-seeking behaviour: some species tend to bite animals more than humans 
(zoophagy vs. anthropophagy), some bite outdoors more than indoors 
(exophagy vs. endophagy)4, and some rest outside more than inside after 
bloodfeeding5. Even within a single species, behaviour can be quite variable. For 
example, host availability6–8, the presence of vector control interventions9,10, and 
seasonality11 have all been shown to influence mosquito host-seeking behaviour. 
So while typical vector control tools are quite efficient at targeting a few 
important vector species, behavioural diversity and plasticity present major 
challenges to the sustainability of vector control12. 
Malaria transmission and epidemiology 
Malaria is one of the most significant infections transmitted by anopheline 
mosquitoes. It has been estimated to cause 435,000 deaths in 201713 and is one 
of the leading causes of child mortality globally14. It is caused by the parasitic 
protozoans Plasmodium falciparum, P. vivax, P. malariae, P. ovale, and P. 
knowlesi which, upon entering a human host, infect liver and blood cells. The 
parasites undergo asexual reproduction within red blood cells, eventually 
bursting out of the cells and causing the high fever characteristic of malaria. 
Severe forms can quickly lead to organ failure, coma, and death. Some parasites 
develop into the sexual gametocyte stage within the red blood cells, which is the 
form capable of infecting a mosquito host.  
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If a mosquito ingests a bloodmeal with male and female gametocytes, they too 
will become infected with malaria. Once ingested, the gametocytes mate to form 
a diploid ookinete which embeds in the wall of the mosquito midgut to form an 
oocyst. Within the oocyst, meiotic division occurs, with subsequent mitosis to 
produce many sporozoites. These sporozoites migrate to the salivary glands of 
the mosquito, where they are injected into subsequent human hosts through the 
mosquito’s saliva during the process of taking a bloodmeal. This process of 
asexual reproduction in the vector makes transmission of malaria efficient; the 
presence of a single oocyst in the midgut wall can produce a mosquito that 
injects many tens to over a hundred sporozoites during subsequent feeding 
attempts15,16. Therefore, a single bite from an infectious mosquito can lead to a 
malaria infection, with 5 infectious bites nearly guaranteeing infection17. 
Development of the parasite within the mosquito, the extrinsic incubation 
period, can take anywhere from 10 days to several weeks depending on the 
parasite species and ambient temperature.  
Lymphatic filariasis transmission and epidemiology 
Lymphatic filariasis (LF), another vector-borne disease, is a major cause of 
chronic disability though it does not contribute to significant mortality. It is 
caused by the filarial nematodes Wuchereria bancrofti, Brugia malayi, and B. 
timori18.  The adult worms reside in the human lymphatic system, causing 
blockages that prevent the efficient movement of lymph. This causes 
lymphoedema of the extremities, elephantiasis, and hydroceles in men. LF 
infects approximately 64.6 million people and caused 1.36 million years lost to 
disability (YLDs) in 201719. 
W. bancrofti is transmitted throughout most tropical and subtropical regions of 
the world and is co-endemic with malaria in many places20. It can be transmitted 
by several different genera of mosquitoes. Anopheles species are the primary 
vectors in rural Africa and the Southwest Pacific. Culex is the primary vector in 
India, Southeast Asia, Egypt, China, and some areas of East and Southern 
Africa. Aedes is important in the Pacific Islands20.  
Female adult worms residing in the lymph nodes release microfilaria (MF) into 
the bloodstream, which is the stage that is infectious to mosquitoes. When a 
mosquito takes a bloodmeal containing MF, they too may become infected21. 
Depending on the vector, MF are often periodic, only appearing in the blood at 
the time when vectors are biting. At other times, they sequester in the tissue of 
the lungs22. Because Anopheles mosquitoes are primarily nocturnal biters, W. 
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bancrofti in anopheline-
transmitted settings is 
nocturnally periodic. 
Once ingested with a 
bloodmeal, MF escape 
the vector midgut by 
burrowing out of the 
midgut wall. They 
migrate to the thoracic 
muscles of the mosquito 
where they develop 
through two larval 
stages (figure 1)23. Once 
moulting to L3 larvae, 
they migrate to the head 
of the mosquito, where they burrow out of the mouthparts during blood feeding 
and actively penetrate the skin through the bite site24. Transmission of LF is 
relatively inefficient compared to malaria for several reasons. First, there is no 
reproduction within the vector; the maximum number of L3 that can develop is 
equal to the number of MF ingested25. In addition, there are several barriers to 
infection in anopheline mosquitoes, most notably the difficulty of bypassing the 
cibarial armature (a structure consisting of specialised “teeth” just anterior to 
the midgut) without being damaged26,27.  Third, L3 are not directly injected with 
the saliva; rather, they are deposited on the skin and must actively find their 
way to the bite site. These factors, combined with many barriers within the 
human host including the necessity of adult worms to find a mate, has led to 
estimates that it takes many thousands of bites from infective mosquitoes to 
lead to an infection that produces MF28. These characteristics have led to 
confidence that LF can be eliminated once transmission falls below some 
threshold above zero29. This threshold is variable between sites, and depends, 
among other things, on vector species30, existing human MF prevalence30, and 
heterogeneity in mosquito exposure31. 
Control and elimination of LF and malaria 
The cornerstones of control for both LF and malaria are transmission blocking 
interventions, although the adopted strategies for each disease are different. For 
malaria, the last 20 years has seen a vast increase in investment in vector 
control strategies, including insecticide-treated nets (ITNs), of which LLINs are 
Figure 1 Relative sizes of the developmental stages of 
Brugia malayi within mosquito hosts. Microfilaria (A) are 
ingested with a blood meal and escape the midgut. 1st (B) 
and 2nd (C) stage larvae exist in the thoracic muscles. 3rd 
(D) stage larvae are transmitted to humans23. 
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the most widely used, and IRS. LLINs are nets that are impregnated with a 
pyrethroid insecticide designed to last up to 3-5 years after passing certain tests 
of durability and quality designed by the World Health Organization (WHO)32. 
However, the effective life of a net depends the brand of net33 and how it is 
used, including how many times it is washed34,35, and whether it is exposed to 
sunlight36. When draped over a sleeping space, they protect the user from 
mosquito bites with a physical barrier as they sleep. In addition, at high enough 
coverage, ITNs provide community protection against malaria transmission by 
killing mosquitoes that come in contact with them37. The personal and 
community protection provided by nets consistently reduce malaria morbidity 
and mortality across multiple settings38,39. In addition, mathematical modelling 
predicts consistent reductions in parasite prevalence between 5-10% across 
multiple transmission settings in Africa at realistic coverage and adherence 
levels40. Epidemiological impact estimates suggest that ITNs are responsible for 
preventing 68% of the averted malaria cases between 2000-201541. However, 
there is a clear trade-off between personal and community protection in cases 
where mosquitoes are not killed by nets, either through repellency, physiological 
resistance, or avoidance: those mosquitoes that avoid a user under a net are 
then free to seek a blood meal from an unprotected individual42. 
During IRS, interior walls of houses are sprayed with an insecticide formulation. 
The spray leaves a residue that can remain effective for up to ten months43, 
although 2-6 months is more typical44. The effective duration depends on the 
insecticide formulation, target surface material and climate45. The effectiveness 
of IRS also relies on the behavioural trait of many mosquitoes to rest on the 
walls of houses after they take a bloodmeal. With a heavy abdomen full of the 
blood, mosquitoes cannot fly very well and require approximately 48 hours to 
digest the blood and produce eggs. While resting, the female is exposed to 
insecticide and is killed. The scale-up of vector control has had a dramatic 
impact on the burden of malaria, particularly in sub-Saharan Africa. Of all 
malaria control efforts, it is estimated that these two interventions have been 
responsible for 78% of the averted cases in the last fifteen years41.  
In addition to vector control, accurate diagnosis, treatment with artemisinin-
based combination therapy, and preventative chemotherapy in vulnerable 
groups comprise the primary suite of interventions to prevent malaria46. Through 
these control tools, as well as the strengthening of surveillance systems and 
highly targeted control approaches, it is the global vision to eliminate malaria. 
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Towards this end, the WHO has set targets of reducing mortality and incidence 
of malaria by 90% in 2030 compared to 201546. 
Rather that prevent transmission 
from mosquito to human, LF 
control efforts have focused on 
preventing transmission from 
human to mosquito. This is 
accomplished through a single 
annual mass drug administration 
(MDA) of the potent 
microfilaricides 
diethylcarbamazine (DEC) or 
ivermectin (IVM) with 
albendazole (ALB). By 
eliminating the MF reservoir, 
ongoing transmission is 
prevented. Because transmission 
is relatively inefficient, it is thought that a “worm breakpoint” exists: a threshold 
MF prevalence in the human population below which transmission is unstable 
and spontaneously moves to zero29,30. Unfortunately, the recommended MDA 
regimens are not very effective at killing adult worms, so annual MDA 
programmes must treat the entire at-risk population for at least 5 years, which 
is the estimated life span of the adult worms47. For this reason, current research 
efforts focus on identifying new drugs48 or regimens49 that are more effective 
against adult worms. Promising results have been obtained using an 8-week 
regimen of doxycycline50, which targets the obligate bacterial endosymbiont 
Wolbachia. However, the prolonged treatment regime makes this a challenging 
strategy to implement at the community level. However, there is a potential 
“missed opportunity” for accelerating elimination with vector control51–53 because 
there is a vector biting rate threshold that is analogous to the worm 
breakpoint30. Therefore, simultaneous deployment of MDA and vector control 
could be synergistic, since the effective implementation of one intervention 
lowers the threshold that the other intervention is required to attain to achieve 
elimination (figure 2). 
Similar to vector control efforts for malaria, MDA has been dramatically scaled 
up within the last 15 years. This is partly due to the commitment from drug 
manufacturing companies to donate the drugs required by MDA campaigns. This 
Figure 2 Depiction of the worm breakpoint values 
at various vector biting rates (dotted line). Solid 
lines represent the stable equilibrium MF 
prevalence at various biting rates. As biting rates 
decrease, worm breakpoints increase, indicating 
that vector control and MDA could work 
synergistically30. 
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made the goal of worldwide LF elimination a reasonable prospect, and the Global 
Program to Eliminate LF (GPELF) was launched in 2000 with an initial target of 
global elimination of the disease in 202054. As of 2017, 7.1 billion doses of drug 
have been distributed55, preventing 96.7 million cases of LF and decreasing the 
global prevalence from 3.55% to 1.47% between 2000-201256. 
Control challenges 
Although the strategies described above have greatly reduced the burden of 
malaria and LF, they are not without their challenges. For vector control, one of 
the largest challenges is the presence of insecticide resistance57. Resistance to 
multiple classes of insecticide has been selected for in many mosquito 
populations, and is now ubiquitous throughout sub-Saharan Africa58. Insecticide 
resistance has the potential to compromise the efficacy of insecticide-based 
control tool59. However, the evidence for this is scarce due to the difficulty of 
isolating the impact of resistance from other confounding factors60.  
Another challenge with these control tools is related to their targeting of specific 
mosquito behaviours, and their reliance on specific human behaviours. LLINs 
only target mosquitoes that bite humans, indoors, at night and IRS only targets 
those mosquitoes that rest indoors. While a significant proportion of mosquitoes 
have these characteristics, especially in sub-Saharan Africa, many do not. 
Exophilic and zoophilic behaviours are common amongst Asian malaria vectors1. 
Despite this, a recent meta-analysis did not find a significantly different impact 
of LLINs between African and Asian settings39, although the Asian studies were 
restricted to India and China. In Papua New Guinea (PNG) and the Southwest 
Pacific, IRS was predicted to have a significant impact on malaria vector 
populations61 due to their sufficient indoor resting habits. However, while IRS 
was able to completely eliminate some species, others were more resilient9. Pilot 
studies on bednets in PNG, with untreated bednets62 as well as permethrin-
impregnated nets63, demonstrated that they had a significant impact on 
sporozoite positivity and biting rates. However, the magnitude decrease was 
relatively small (from 689 to 483 bites/person/night).  
In addition, humans may decide not to use nets for a variety of reasons64. Even 
if they do use them, humans go to bed at various hours of the night and some 
are bound to be awake and out of their nets when mosquitoes are biting. Malaria 
transmission that still occurs despite the effective deployment and universal 
coverage of LLINs, or any vector control tool, is called residual malaria 
transmission65. The magnitude of residual malaria transmission in a location 
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depends on a number of factors, including the level of outdoor exposure, the 
propensity of vectors to seek non-human bloodmeals, and insecticide-induced 
avoidance of vector control measures, all of which can make mosquito 
populations more resilient65.  
In addition, there is increasing evidence that shifts in mosquito behaviour or 
composition may result in a post-intervention population that is less likely to 
come into contact with LLINs. At the closure of the Global Malaria Elimination 
Program (GMEP) of the 1950s and 1960s, which was largely driven by IRS with 
dichlorodiphenyltrichloroethane (DDT), one of the primary cited causes for the 
failure of the programme was behavioural resilience in Anopheles vector 
populations66. The primary difficulty in interpreting this data is the fact that 
many populations demonstrating behavioural shifts at the time were likely 
populations of morphologically indistinguishable species. Therefore, changes in 
behaviour within a population may have been due to taxonomic replacement. 
More recently, shifts to biting later in the morning have been seen in Benin67, 
greater outdoor biting in Equatorial Guinea68, and changes in species 
composition favouring those mosquitoes that do bite earlier in Tanzania69. These 
studies have benefited from modern molecular techniques allowing more 
accurate identification of species. However, all are still limited by the fact that 
they are observational studies and are unable to provide evidence of causation. 
In addition, there are relatively few studies documenting modern behavioural 
shifts despite the widespread use of LLINs. The underlying mechanism for these 
shifts is currently unknown.  They may be caused by an opportunistic trait of 
some mosquitoes to find bloodmeals whenever or wherever they are available, 
with no particular fidelity to a particular biting time or location63,70,71. 
Alternatively, they may be durable evolutionary changes which are being 
selected for by vector control tools, as evidenced by a permanent change in 
biting behaviour in the Solomon Islands after the DDT spray campaign9,72. 
However, the genes that govern feeding behaviour in anophelines have yet to be 
identified73. Regardless, behavioural resistance has the potential to compromise 
the efficacy of control programmes12, but there is currently little empirical 
evidence linking behavioural shifts to control failure. 
Challenges associated with MDA largely relate to the difficulty in achieving high 
coverage for many successive years in a row. Coverage can be hindered by the 
inaccessibility of the communities74, health system75, political, or financial 
constraints76, systematic non-access to certain individuals77,78, and migration79–
82. The inaccessibility of communities is particularly difficult to overcome, as it 
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not only results in fewer individuals receiving treatment, but a general distrust 
of the health system due to infrequent contact and hindered ability to 
communicate health promotion messaging74. In addition, although there are 
guidelines for when to stop MDA and begin surveillance for ongoing transmission 
(called transmission assessment surveys, or TAS83), the thresholds for 
transmission cessation are context-specific and often unknown29,30,84. Therefore, 
many countries have either had to continue giving MDA for many years beyond 
what was anticipated85, or have found evidence of transmission despite meeting 
TAS-defined thresholds, resulting in the need to start over again86. 
The degree to which these challenges are experienced depends on the setting. 
Those areas that have more behaviourally “challenging” vectors stand to gain 
less from an LLIN intervention than those areas that have highly anthropophagic 
and endophagic vectors. Likewise, areas with strong political will backed up by 
appropriate financial resources and accessible populations will likely face 
significantly fewer challenges related to MDA compared to areas without these 
characteristics. This leads to the obvious question: why do homogeneous control 
efforts continue to be implemented across heterogeneous contexts, despite 
historical evidence indicating this may not be the best strategy? 
Malaria and LF in Papua New Guinea 
In Papua New Guinea (PNG), the challenges described above are at the forefront 
of the fight against vector-borne disease. Malaria and LF are both major 
problems in PNG. Malaria is perennially transmitted in the lowland and island 
areas, and the central highlands that run the length of the main island are prone 
to outbreaks87. A recent survey estimated a national mean parasite prevalence 
of 12.1%88. All four species of malaria parasite are actively transmitted in PNG 
and therefore coinfections of species and strains are common. However, only P. 
falciparum and P. vivax are the species associated with severe disease. Most of 
PNG’s population is also at-risk of infection with LF, with only a few areas in the 
highland provinces where transmission is not stable. It is estimated that 18.5% 
of the population is MF positive, with over 40% positivity at some sites89. 
The major anopheline vectors of LF and malaria in PNG fall within a group of 
thirteen species called the An. punctulatus group90. Within this group are the 
species An. punctulatus, An. koliensis, An. sp. nr punctulatus, An. clowi, and An. 
rennellensis, and 8 members of the An. farauti complex, including An. farauti 
s.s., An. hinesorum, An. torresiensis, An. farauti 4, An. farauti 5, An. farauti 6, 
An. irenicus, and An. faruati 8. Of these 13 group members, An. punctulatus, 
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An. farauti s.s., An. hinesorum, An. farauti 4, and An. koliensis are the major 
vectors due to their wide distribution and relative abundance compared to the 
others91.  In addition, four other species have been incriminated as minor 
vectors of malaria, including An. subpictus, An. karwari, An. longirostris, and An. 
bancroftii. There may be even more than this, as An. longirostris has been 
shown to be a complex of nine species92, and An. bancroftii, four species93. Each 
of these vectors exhibits different host-seeking behaviour and habitat 
preferences (Table 1), although all species tend to rest outside after blood-
feeding94. Therefore, the species composition from site to site can vary 
substantially. Phenotypic resistance to DDT and pyrethroids has not been 
detected in any of the major malaria vectors across multiple areas of the 
country95. 
Table 1. Characteristics of the five major malaria vector species in Papua New Guinea. 
Species Distribution Larval Habitat Behaviour 
An. farauti Throughout 
PNG in 
lowland 
coastal 
areas96 
Brackish 
water96 
Bites throughout the night97 
with some tendency for 
early biting before 9pm98; 
feeds on different host 
species, depending on 
availability, with one study 
reporting a range of HBI 
between 9-83% between 
villages94; tendency for 
exophagy98 
An. 
punctulatus 
Throughout 
PNG in 
lowland inland 
areas and 
foothills96 
Ephemeral 
pools, often 
associated 
with human 
disturbance96 
Peak biting late night after 
12am97; bites equally 
indoors and outdoors99 
An. koliensis Throughout 
PNG in 
lowland inland 
areas and 
foothills96 
Ephemeral 
pools but also 
swamps and 
natural 
ground 
pools96 
Peak biting late night after 
12am97; will feed on animals 
but prefers humans where 
available94 
An. hinesorum Inland 
lowland 
Natural 
ground 
Assumed anthropophilic 
because of sporozoite 
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regions96 pools96 rates91; peak biting in early 
night time hours before 
9pm97 
An. farauti 4 Inland 
lowland 
regions north 
of the central 
range96 
 Feeds on different host 
species, depending on 
availability8; bites 
throughout the night97 
 
The GMEP was active in PNG beginning in 1958, primarily using IRS with dieldrin 
and in 1960, DDT. IRS with DDT continued to be scaled up until 1969, at which 
point over half of the at-risk population in PNG was covered, including all of the 
study sites in this thesis100. It was at this point that the goal of eradication was 
abandoned and a position of malaria control taken up101. Regular DDT spraying 
continued until the late 1970s, and in the early 1980s a programmatic 
evaluation determined that it was not effective in reducing malaria in lowland 
regions102. DDT was discontinued from 1984101.  The DDT spray campaign in the 
Solomon Islands, a neighbouring island nation in the Southwest Pacific, 
witnessed behavioural resilience in the local population: mosquitoes exhibited a 
significant shift in biting times from the middle of the night to early evening 
hours. In addition, there was a significant shift to biting outdoors more than 
indoors9. Vector control efforts waned in the early 1980s, and continued at very 
low levels until 2004, when the PNG government secured a grant from the 
Global Fund to Fight Aids, Tuberculosis, and Malaria (GFATM) to complete the 
first nation-wide, free distribution of LLINs. These activities occurred between 
2004 and 2009103.  
The Pacific Programme to Eliminate Lymphatic Filariasis (PacELF) was 
established in 1999104, of which PNG is a member. However, MDA for LF has 
been sparse and restricted to various small-scale clinical trials to assess 
treatment efficacy105–107, and a few successive annual rounds in the island 
provinces.  Logistical and financial challenges have been numerous, and have 
prohibited large-scale, coordinated, nationwide MDA89. Small bednet trials 
indicated that untreated nets could reduce transmission of LF108, but at the time 
of the LLIN mass distribution campaign, no comprehensive evaluation of the 
impact of a programmatic LLIN distribution on LF had been conducted in PNG or 
elsewhere. 
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Hypotheses, aims, and objectives 
Between 2004 and 2009, PNG experienced its first large-scale vector control 
effort targeting malaria vectors since the DDT spraying of the 1960s. Since 
malaria vectors in PNG are behaviourally diverse and also transmit LF, this 
presented a valuable opportunity to test the hypotheses that 1) LLINs may not 
be as effective in areas like PNG, where a wide range of vector biting behaviour 
is the status quo, and 2) the impact of LLINs may extend beyond malaria to 
other vector-borne diseases like LF. Simultaneously, PNG has been struggling to 
sustain its MDA efforts, so even with vector control, 3) LF elimination may be 
more achievable with alternative drug regimens that could overcome challenges 
of typical MDA. 
The overarching aim of this thesis is therefore to evaluate the efficacy of existing 
and emerging interventions to prevent vector-borne disease transmission and 
eliminate filariasis in PNG. This is addressed through three objectives: 
1. to evaluate the impact of a nationwide LLIN distribution on vector density, 
behaviour, and species composition,  
2. to evaluate the impact of LLINs on malaria and LF transmission and disease 
prevalence, and  
3. to evaluate the efficacy of complementary, integrated control measures to 
increase the likelihood of LF elimination. 
Summary of the studies 
To achieve the aim of the thesis, a series of studies was completed from 2008-
2013 in PNG (Table 2). Publication dates ranged from 2013-2017. A statement 
of the author’s contribution to each publication, signed by all co-authors, can be 
found in Appendix 1. A full list of all the author’s publications can be found in 
Appendix 2. The published works can be found in Appendix 3. 
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Table 2. Characteristics of the four publications submitted as part of this thesis.  
# Journal 
and date 
Title First 
author(s) 
Co-authors 
1 New 
England 
Journal of 
Medicine 
 
August 
2013 
Insecticidal Bed Nets and 
Filariasis Transmission in Papua 
New Guinea109 
L. Reimer 
E. 
Thomsen 
D. Tisch 
C. Henry-
Halldin 
P. 
Zimmerman 
M. Baea 
H. Dagoro 
M. Susapu 
M. Hetzel 
M. Bockarie 
E. Michael 
P. Siba 
J. Kazura 
2 Malaria 
Journal 
 
January 
2016 
Malaria transmission dynamics 
surrounding the first nationwide 
long-lasting insecticidal net 
distribution in Papua New 
Guinea110 
L. Reimer E. Thomsen 
G. Koimbu 
J. Keven 
P. Siba 
J. Kazura 
M. Hetzel 
P. 
Zimmerman 
3 The 
Journal of 
Infectious 
Diseases 
 
March 
2017 
Mosquito behaviour change 
after distribution of bednets 
results in decreased protection 
against malaria exposure111 
E. 
Thomsen 
G. Koimbu 
J. Pulford 
S. Jamea-
Maiasa 
Y. Ura 
J. Keven 
P. Siba 
I. Mueller 
M. Hetzel 
L. Reimer 
4 Clinical 
Infectious 
Diseases 
 
February 
2016 
Efficacy, safety, and 
pharmacokinetics of 
coadministered 
diethylcarbamazine, 
albendazole, and ivermectin for 
treatment of Bancroftian 
filariasis112 
E. 
Thomsen 
N. Sanuku 
M. Baea 
S. Satofan 
E. Maki 
B. Lombore 
M. Schmidt 
P. Siba 
G. Weil 
J. Kazura 
L. 
Fleckentstein 
C. King 
Each of the thesis objectives were informed by multiple studies, and some of the 
results from earlier studies informed future analyses and research. For example, 
results from studies 1 and 2 directly influenced the hypotheses and analysis 
methods presented in paper 3. Likewise, the results from paper 1 stimulated 
further research questions that informed the approach used in paper 4. The 
study characteristics, how they relate to the thesis objectives, and how they 
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relate to each other are shown in figure 3. 
 
Figure 3 Venn diagram showing the three major objectives of the thesis (coloured boxes), 
and the papers that contributed to each objective. Arrows indicate where results from one 
paper influenced the approach taken on another. 
A timeline for all studies is show in figure 4. Most of the sample collection 
occurred between 2008-2012, sample and laboratory analysis between 2009-
2013, and data analysis and writing between 2011-2016. 
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Figure 4 Timeline of various activities for each paper. Star indicates publication date.
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The studies were completed in different parts of PNG. Paper 1109 was conducted 
in five villages in the Dreikikir District of East Sepik Province, paper 2110 was 
conducted at these five villages as well as six more along the north coast of 
Madang Province, paper 3111 was conducted in three villages along the Ramu 
River Valley of Madang Province, and paper 4112 was conducted at the Dreikikir 
Health Centre with individuals recruited from the village of Tau approximately 10 
km south of the health centre (figure 5).
 
Figure 5 Map of Papua New Guinea with insets showing locations of study sites for the 
four papers. 
Paper 1 - Insecticidal Bed Nets and Filariasis Transmission in 
Papua New Guinea 
Rationale 
The challenges of attaining high drug coverage in an LF MDA programme for 
multiple consecutive years have led to concern that a single global strategy of 
elimination may not be resilient, and that lack of vector control may hinder the 
progress of LF elimination51,52,113,114. There are many areas where Anopheles 
spp. transmit both LF and malaria parasites, providing the opportunity for 
malaria control efforts to benefit the GPELF. Currently, the most widely 
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implemented vector control intervention for malaria is LLINs. However, data are 
lacking on how LLINs will complement MDA to achieve LF elimination goals. 
Methods 
Entomological and epidemiological data on LF were collected from five villages in 
an area of PNG that had previously received MDA for five years ending in 
1998115, and which received LLINs as part of a mass distribution campaign in 
August of 2009. Mosquitoes were collected by human landing catch every month 
for 26 months before the LLIN distribution and 11-36 months after the LLIN 
distribution, depending on the village.  Collected mosquitoes were stored 
according to the hour they were collected. All mosquitoes were morphologically 
identified, and a portion of the mosquitoes were confirmed to species and 
assessed for the presence of W. bancrofti DNA by PCR116. Another portion were 
dissected to look for W. bancrofti in various body tissues. A parasite prevalence 
survey was conducted approximately one year prior to the LLIN distribution 
among consenting adult volunteers and children >1 year old from the five study 
villages. Venous blood was drawn at night, 1mL was passed through a 5µm 
polycarbonate filter, the filter was stained, and the microfilariae were counted. 
LLIN use surveys were conducted in November 2008 and again in September 
through December 2009 by asking adults ≥18 years and children ≥1 year (or 
their parent/guardian) if they had slept under an LLIN the previous night. Daily 
human biting rates were estimated as the mean number of host-seeking 
anophelines collected by human landing catch in a 12-hour period.  Daily 
transmission potentials were calculated by multiplying the daily biting rate per 
mosquito species in each village by the mean number of L3 larvae per mosquito. 
The mean daily value for each village was then multiplied by 365 to calculate the 
annual transmission potential (ATP), an estimate of how many infective L3 
larvae are inoculated per person per year. To estimate the likelihood of 
transmission extinction, a previously developed population dynamic model of LF 
transmission30 was fitted to age-stratified MF prevalence data collected from the 
five villages. Estimates of threshold biting rates were obtained from the model 
and compared to observed biting rates before and after LLIN distribution to 
determine the likelihood of transmission cessation. 
Results 
LLIN use shortly after the distribution was between 75-90% (n=911). 21,899 
anophelines were collected over the 3-year period from 2007 to 2010; 20,345 
during the 26 months before LLIN distribution and 1,554 during the 11 months 
after LLIN distribution. Overall, the proportion of anophelines positive for W. 
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bancrofti DNA decreased from 19.4% (n=761) before LLINs to 14.9% (n=248) 
after LLINs (Fisher’s Exact, p=0.13). The decrease in mosquitoes infected with 
any stage larvae was more pronounced, with 1.8% An. punctulatus infected 
before, and 0.4% after LLIN 
distribution (n=8,859 mosquitoes 
dissected, Fisher’s exact 
p=0.005). No mosquitoes 
containing infective L3 larvae were 
found in any village after LLIN 
distribution, so while ATP was 
similar in the two years prior to 
the LLIN distribution, it dropped to 
zero afterwards (figure 6).  There 
was a significant shift in the biting 
time of mosquitoes to earlier hours of the evening, decoupling the previously 
close association between hourly biting rates and MF density in the blood (figure 
7). The probability that transmission was interrupted was <1% in all five villages 
before LLINs. After LLINs, the probabilities increased to 4.9%, 7.7%, 90.5%, 
95.8%, and 61.5%, and were higher in those villages with a lower MF 
prevalence prior to the LLIN distribution. 
 
Figure 7 Changes in anopheline biting time following introduction of LLINs and nocturnal 
periodicity of microfilaremia in two Papua New Guinea study participants. Microfilaria (MF) 
ratios (as calculated in 117) are indicated by purple circles and a purple line. Anopheline 
biting times before LLINs were introduced are indicated by the blue line. Biting times 
after they were introduced are indicated by the green line109. 
Figure 6 Annual transmission potential (L3 
inoculated per person per year) before LLINs 
(2007-2008 and 2008-2009) and after LLINs 
(2009-2010). Modified from 109.  
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Summary interpretation and conclusion 
This study documented LF transmission at monthly timepoints before and after 
an LLIN distribution. The decrease in mosquito abundance observed in the study 
is likely due to the LLIN distribution, although other factors, such as seasonal 
fluctuations or collector bias may have contributed as well. Collectors were local 
members of the community, and were therefore unblinded to the intervention 
and were in fact made aware of its intended impact. Regular monitoring of 
mosquito collectors was conducted throughout the study to ensure consistent 
methodology. Consistently low mosquito densities for up to 3 years after the 
LLIN distribution suggest that this was not caused by a natural event.  
The proportion of mosquitoes positive for parasite DNA did not change 
significantly after the intervention, but the proportion positive by dissection 
decreased. This indicates that mosquitoes were still taking microfilaraemic 
bloodmeals, but were not sustaining parasite development.  This may have been 
due to a decrease in the age structure of the mosquito population, a common 
impact of LLINs118. A decrease in life span would have prohibited the 
development of infective stage larvae within the mosquito population, which 
typically takes 13 days27. In addition, desynchronization of biting time and peak 
blood MF densities may have resulted in fewer MF being ingested, further 
decreasing the likelihood of a mosquito becoming infective. 
The statistics used to analyse the data in this study did not incorporate methods 
to handle variation due to random effects. In addition, the data violated the 
statistical assumption that observations were independent. This may have 
obscured the true variation in the data likely caused by the presence of LLINs.  
The population modelling suggests that the likelihood of transmission cessation 
was high in those villages with a low initial MF prevalence, indicating that LLINs 
may be an important stand-alone tool to reach elimination in these settings. 
Alternatively, they may act synergistically with MDA to help lower worm 
breakpoints. 
Paper 2 - Malaria transmission dynamics surrounding the first 
nationwide long-lasting insecticidal net distribution in Papua 
New Guinea. 
Rationale 
PNG has a very diverse malaria vector population, with approximately five major 
vector species and an additional four important secondary vectors90,91. Each of 
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the five species exhibit different behavioural characteristics and habitat 
preferences90,91,119. In 2009, the PNG government distributed LLINs nationwide 
to prevent malaria transmission. However, the primary vectors bite both indoors 
and outdoors, humans and animals, and at various times of the night. With an 
intervention targeted primarily at late-night indoor biters, it was crucial to 
document the impact of LLINs on mosquito behaviour, abundance, and malaria 
transmission. 
Methods 
Mosquitoes were collected by human landing catch in 11 different villages in the 
Madang and Dreikikir Provinces of PNG. In Madang, three coastal and three 
inland villages were selected. The villages in Dreikikir were the same as those 
used in paper 1109. Collections were performed monthly in all villages for one 
year prior to the LLIN distribution and one year after the distribution, and 
continued on a bimonthly or quarterly basis in select villages for a third year. 
Mosquitoes were stored according to the hour, date, and household, identified 
morphologically, and species-confirmed by PCR120. To establish infection rates, 
mosquitoes were screened for P. falciparum and P. vivax circumsporozoite 
protein by enzyme-linked immunsorbent assay (ELISA)121. During collections, 
environmental conditions were also assessed on an hourly basis, including 
rainfall, wind, and cloud cover. In addition, the number of humans and animals 
present were counted. To identify the determinants of mosquito abundance and 
infection prevalence, generalised estimating equations (GEE) were used that 
included collector, house, village, date, and hour as random effects and 
presence of LLINs, rainfall, cloud cover, and wind as fixed effects (and mosquito 
species when the dependent variable was infection prevalence). Mean human 
biting rates were calculated per village and year, and post-hoc comparisons of 
biting rates within villages from year to year were performed with t-tests. 
Entomological inoculation rate (EIR) was calculated as the mean number of 
bites/person/year multiplied by the sporozoite prevalence. Median biting times 
were calculated per village per year and comparisons between years were made 
with Mann-Whitney U tests.  
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Results  
Human biting rates significantly decreased in 8 of the 11 villages after the 
distribution of LLINs, and the EIR decreased in all but one village (figure 8). 
 
Figure 8 Anopheline biting rates (MBR, left side) and entomological inoculation rate (EIR, 
right side) in the three study regions. In all cases, year 1 is before the LLIN distribution 
and years 2 and 3 are after the distribution. Light blue bars on the EIR graph represent P. 
vivax and dark blue bars represent P. falciparum. Asterisks indicate villages where 
significant decreases in biting rates occured after LLIN distribution. Modified from 110. 
In addition to LLINs, rainfall the previous month, cloud cover, and wind all had a 
significant impact on mosquito abundance. After LLINs, there was a significant 
shift to earlier biting times across multiple villages in both An. punctulatus and 
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An. farauti s.s. In addition, species composition significantly changed, with An. 
farauti s.s. increasing in proportion in coastal areas, and An. punctulatus 
increasing in proportion in inland areas. Sporozoite prevalence significantly 
decreased in the first year after LLIN distribution, but significantly increased in 
the second year after the intervention. Of the three major vector species found 
(An. punctulatus, An. koliensis, and An. farauti s.s.), when controlling for village 
and study year, all were equally likely to carry P. vivax sporozoites, but An. 
punctulatus was more likely to carry P. falciparum sporozoites.  
Summary interpretation and conclusion 
LLINs contributed to a significant reduction in mosquito abundance and malaria 
transmission across multiple mosquito species and locations, despite the 
presence of exophagic and early biting behaviours. Abundance remained low for 
over two years after the introduction of the intervention, with seasonal rainfall 
patterns staying consistent year to year.  The impact of LLINs may have been 
due to their community effect in reducing exposure122. The intervention was also 
associated with changes in mosquito biting times, although the epidemiological 
significance of these changes requires further investigation.  
EIRs were also reduced and stayed low for the duration of the study. However, 
this reduction was a result of the reduction in biting rates rather than sporozoite 
prevalence, because sporozoite prevalence rebounded between years 2 and 3 
post-intervention. This observation may have been a result of a low sample size, 
which is frequently a challenge in post-intervention settings. However, it does 
demonstrate that there was considerable residual transmission, and that a 
resurgence in mosquito density would be accompanied by an increase in 
transmission intensity as well. 
Although some statistical analyses (the GEE) included methods to effectively 
handle non-independence of observations, random effects, and non-normal 
response variables, other statistical analyses did not, such as the Mann-Whitney 
U test to look at shifts in biting times. A more comprehensive random effects 
model would have allowed further elucidation of sources of variation in the data 
and perhaps would have provided more power to detect differences. 
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Paper 3 - Mosquito behaviour change after distribution of 
bednets results in decreased protection against malaria 
exposure 
Rationale 
Historically, changes in mosquito behaviour in response to vector control 
interventions have presented challenges for malaria control66,123,124. Since 2000, 
bednets have dominated as the most widely used malaria vector control tool 
worldwide, and several studies have documented changes in biting behaviour 
associated with net distributions68,69,72. However, there is a relatively poor 
understanding of the epidemiological consequences of these changes. 
Methods 
Estimates of human exposure to 
mosquito bites and human malaria 
prevalence were investigated in 3 
villages in the Ramu River Valley of 
Madang Province in PNG before and 
after an LLIN distribution in January 
2009. Mosquitoes were collected in two 
of these villages by indoor and outdoor 
human landing catch, stored by hour of 
collection, and identified by PCR120. 
Lysates were analysed by ELISA121 for 
the presence of P. falciparum or P. vivax 
sporozoites. Human movement inside 
and outside as well as sleeping patterns 
were assessed as part of a national household survey125. A malaria prevalence 
survey was conducted three times during the study: once before the LLIN 
distribution in 2008, and twice after the distribution in 2009 and 2011. These 
surveys were conducted in the same villages as the mosquito collections and one 
additional village in close proximity. Estimates of exposure to mosquito bites 
were calculated by multiplying the outdoor and indoor hourly biting rates by the 
proportion of the human population outside, inside, and in bed at each hour. 
These estimates were calculated for different age groups as well as for a 
theoretical net user and non-net user. Estimated values of exposure and 
protective efficacy for users and non-users were compared between age groups 
Figure 9 Total estimated exposure to 
bites for a non–net user before LLINs 
(2008) and after LLINs (2009-2011) in 
both study villages. Points sharing the 
same letter were not statistically 
different using a Kruskal-Wallis test with 
pair-wise comparisons. From 111. 
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and years using generalised linear mixed models, with year by age group as the 
fixed effect, and house and date of collection as random effects. 
Results 
A total of 41,757 anopheline mosquitoes were captured during the four-year 
period, with 99% of them identified as An. farauti 4. Biting rates initially 
decreased after the LLIN distribution 
but increased significantly in both 
villages within 2 years (Figure 9). The 
median time of biting in both villages 
was earlier after the LLIN distribution 
than before. Prevalence of malaria 
sporozoites was consistent across all four years. The true protective efficacy of 
nets was greater in younger age groups but decreased over the study period in 
all age groups due to the shift to earlier biting times and greater interaction with 
humans before bed time hours (figure 10). Only one village showed a consistent 
decrease in malaria prevalence from 2008-2011, with the other two villages 
either displaying no change or increasing (figure 11). 
Summary interpretation and conclusion 
The data presented in this paper demonstrate a reduction in mosquito 
abundance immediately after the LLIN distribution, with a resurgence 2-3 years 
Figure 10 The protective efficacy of LLINs 
(the proportion of exposure prevented by 
using an LLIN) by age group in both 
Kokofine (A) and Mauno (B) villages 
before (2008) and after LLIN distribution 
(2009-2011). Modified from 111. 
Figure 11 Human malaria prevalence in 
Kokofine (A), Mauno (B), and Kesowai (C) 
villages before (2008) and after (2009 and 
2011) an LLIN distribution.  Bars marked 
with an asterisk are statistically different 
from 2008 by a chi-square test. From 111. 
24 
 
later coupled with shifts to earlier biting. Estimations of mosquito-human contact 
taking into account the behaviour of both revealed that nets provided less 
personal protection after the distribution, because the shift in biting times 
resulted in more exposure during hours that people were awake and out of their 
nets. However, this study design had several limitations. First, paired indoor and 
outdoor mosquito collections were not conducted for the duration of the study. 
Previous studies have documented decreases in endophagy following the 
deployment of indoor interventions69, which is a phenomenon that we were 
unable to capture. Second, human landing catches were not conducted before 
6pm, so a significant amount of mosquito exposure may have been omitted from 
the analysis. If early and outdoor exposure was underestimated or if there was 
indeed a shift in endophagy, the analysis would have underestimated the 
magnitude of decrease seen in personal protection.  
Other factors may have contributed to the resurgence in mosquito densities. 
First, environmental factors may have made for more favourable conditions in 
years 2 and 3. This study did not measure climatic conditions. However, rainfall 
data collected as part of paper 2 in Madang (~70km away from the study sites) 
indicated that there were no major seasonal patterns of rainfall. The study 
design, which included brief collection bouts separated by many months of no 
collections, may have highlighted week-to-week variation and obscured any 
long-term trends. Second, physiological resistance has been shown to decrease 
the operational impact of nets126. However, mosquito populations from this 
region of PNG have been shown to be susceptible to the insecticide used in 
LLINs95. Lastly, a decrease in LLIN use may have contributed to increases in 
mosquito densities, but based on two bednet surveys, the one included in this 
study and another independent survey in the same villages in 20128, LLIN use 
appears to have increased over this study period.  
While LLINs did not have the intended impact on malaria prevalence, there was 
significant variation in malaria burden between villages and years. There may be 
many factors driving this variation. First, access to appropriate malaria 
diagnostics and treatment.  Artemisinin combination therapy was only rolled out 
in this area at the end of 2011, and treatment failures with the previous 
combination of chloroquine plus sulfadoxine-pyrimethamine reached 18.5% in 
children infected with P. falciparum in PNG127. Therefore, the population may 
have been receiving inadequate treatment throughout the study period. Second, 
a higher baseline density of mosquitoes may make the population more resilient 
to control, which may be analogous to the well-known phenomenon of IRS 
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applications being more effective when deployed before the start of the malaria 
transmission season128. Finally, the study design did not allow measurement of 
seasonal fluctuations in malaria prevalence, so while the surveys were 
performed at the same time every year, the variation may have been typical. 
However, seasonal fluctuations in malaria incidence in this region have been 
shown to be remarkably stable129. 
Paper 4 - Efficacy, safety, and pharmacokinetics of co-
administered diethylcarbamazine, albendazole, and ivermectin 
for treatment of Bancroftian filariasis 
Rationale 
The GPELF is grounded in the strategy of annual MDA for at least five years of 
ALB with either DEC or IVM47, depending on co-endemicity with onchocerciasis, 
for which DEC is contraindicated. However, numerous challenges have resulted 
in some programmes failing to reach elimination targets with this strategy. 
Triple-drug therapy could have longer lasting microfilaricidal properties, but the 
efficacy, safety, and pharmacokinetic profile of IVM+DEC+ALB (IDA) has never 
been investigated. 
Methods 
A single-blinded, randomized controlled trial with two treatment arms (DEC 6 
mg/kg + ALB 400 mg or DEC 6 mg/kg + ALB 400 mg + IVM 200 μg/kg) was 
conducted with individuals heavily infected with W. bancrofti in PNG. 24 
individuals from Tau village in East Sepik Province met the inclusion criteria and 
were recruited to participate in the study. Participants were stratified by sex and 
randomly allocated to one of the two treatment arms. The night prior to 
treatment, a clinical assessment was performed, including physical examination, 
evaluation of lymphadenitis, lymphedema, and scrotal abnormalities in men, 
vital signs, urinalysis, blood hemoglobin levels, and subjective symptoms. The 
following morning, a blood sample was taken to evaluate baseline alanine 
transaminase (ALT), aspartate transaminase (AST), and creatinine levels, as well 
as drug levels. Blood draws were performed at 1, 2, 3, 4, 6, 8, 12, 24, 36, 48, 
and 72 hours, and 7 days post dose. Thorough physical exams (as described 
above) were performed at hours 4, 8, 12, 24, 48 and day 7 post dose. The blood 
draws at 36 hours and 7 days were performed at night to assess MF levels. 
Subsequent night bleeds were performed 1 and 2 years after treatment. MF 
levels were assessed by passing 1mL of blood through a 5µm polycarbonate 
filter, washing and staining the filter, and counting the number of MF with a 
26 
 
microscope. Circulating adult worm antigen levels were measured using an 
ELISA assay130. 
Results 
The percent reduction in MF was significantly greater in the IDA group compared 
to two-drug group at all follow ups (Figure 12). 
Figure 12 Percent reduction in microfilaria levels compared to pre-treatment at 36 hours, 
7 days, and 1 year following treatment with either diethylcarbamazine, albendazole, and 
ivermectin (closed circles) or diethylcarbamazine and albendazole (open triangles)112. 
While 11 of the 12 participants in the two-drug group were MF positive 1-year 
post-treatment, all participants in the three-drug group were MF negative. The 6 
individuals available for follow up after 2 years remained MF negative. Adult 
worm antigen levels decreased in both groups, but was more significant in the 
IDA group. Adverse events (AEs) were similar in both groups and consisted of 
fever, arthralgia, pruritis, and proteinuria/haematuria. All AEs (except fever, 
which was treated with paracetamol) were self-limiting and most dissipated 
within 7 days. Both groups had a similar proportion of participants experiencing 
any AE, but the median number of AEs was larger in the IDA group. 
Pharmacokinetic analysis indicated that there was no significant interaction 
between IVM and DEC or ALB. 
Summary interpretation and conclusion 
Participants in both groups showed reductions in MF densities. However, 
participants in the IDA group showed greater reductions and all of these 
participants who were available for follow up remained MF negative 2 years post 
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treatment. A greater reduction in adult worm antigen in the IDA group suggests 
that this treatment was more effective in killing adult worms. However, as both 
groups were antigen positive after treatment, the long-term reductions in MF 
densities seen in the IDA were likely due to embryostatic or embryocidal effects.  
The AEs observed in both groups are consistent with previous studies that have 
documented the effects of mass killing of MF131,132. These include headache, 
fever, pruritis, arthralgia, and urine abnormalities. The IDA group had a greater 
number of AEs, which may have been due to greater efficacy against MF and 
adult worms. The pharmacokinetic parameter estimates of ALB (and its 
metabolites) and DEC were not different between treatment groups, indicating 
that IVM did not change the absorption or clearance of the other two drugs. 
This study had a relatively small sample size, primarily powered to determine 
the presence of drug-drug interactions. Therefore, the preliminary efficacy data 
obtained in this trial must be verified with further studies. 
Discussion 
Impact of LLINs on mosquito abundance, behaviour, and 
composition 
A large thrust of this thesis was the evaluation of how LLINs, which target 
endophagic and anthropophagic mosquitoes, work in a diverse vector 
environment. There has been a historic precedent that these types of 
“monotherapies” for vector control are inadequate66,123,124,133. The residual 
malaria transmission that remained after the DDT IRS campaigns of the 1950s 
and 1960s was one of the reasons cited for the ultimate failure of the GMEP123. 
Now that we are 15 years into the “age of the LLIN”, it is important to quantify if 
and how LLINs are failing so that we are better informed to establish 
complimentary interventions. 
In PNG, the first nationwide LLIN distribution campaign had dramatic successes. 
In paper 1109 and paper 2110, it was demonstrated that the abundance of vector 
species was significantly reduced after the distribution campaign. This impact 
was seen across several geographical regions of the country, and remained for 
up to three years after the intervention was in place. One result of this change in 
density was also a change in species composition, presumably because some 
vector species were more resilient to the intervention than others. This has also 
been documented in other areas, where the predominant vectors after LLINs are 
those that are more catholic in their biting behaviour69,134. These shifts in 
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composition may help to inform which species are likely to contribute the most 
to residual transmission of malaria and other vector-borne diseases in different 
regions of the country. Of the three major vectors in PNG, An. koliensis appears 
to be the most impacted by LLINs, followed by An. punctulatus and finally An. 
farauti s.s. This is understandable given the previously well-established early 
outdoor feeding behaviour of An. farauti s.s.97. 
A resurgence in mosquito abundance after an initial decline was only seen in the 
sites used in paper 3111, where the dominant vector was An. farauti 4 and there 
was an incredibly high baseline density of mosquitoes prior to the net 
distribution. One potential cause of this rebound may have been the shift in 
behaviour to biting at earlier hours of the evening. As a greater proportion of 
mosquitoes bite when humans are outdoors, these mosquitoes are then able to 
lay eggs and contribute to the next generation. Changes in biting times were 
also seen in papers 1109 and 2110 across multiple species, so understanding the 
impact of these changes over the longer term will be important to inform the 
continued use of LLINs. The relatively rapid rebound seen in paper 3111 may 
have been a consequence of the already high mosquito population density seen 
here, and other areas may experience similar rebounds in the future. Other 
potential contributors to the rebound could have been a change in LLIN usage, a 
decrease in the effectiveness of the nets, or presence of physiological resistance 
in mosquitoes. However, these appear unlikely as net use remained high 
throughout the study period8, LLINs remain effective for up to 5 years in typical 
use conditions in PNG135, and there has been no detection of physiological 
resistance in mosquitoes of PNG95,136. 
In-depth analysis of the true exposure to mosquito bites, taking into account 
human behaviour and changing vector behaviour, revealed insights into the 
consequences of these behavioural shifts. The first insight relates to how 
personal protection can change with dynamic vector behaviour. Previously, a 
similar analysis indicated that despite behavioural shifts of An. funestus to 
feeding at early dawn, LLINs still provided high personal protection of >80%137. 
However, in paper 3111, personal protection decreased significantly over the 
three-year period surrounding the net distribution, providing only ~30% 
protection at the end of the study. This is largely due to the temporal 
relationship between human outdoor activity and the scope of shift in biting 
times. If the shift occurs when people are still largely inside, as in Moiroux et al. 
2014137, then the protective efficacy of nets will change little. However, if the 
shift spans the time humans are rapidly moving from inside to outside, or vice 
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versa, as seen in paper 3111, the behavioural shift will have a major impact on 
how much exposure can be prevented by using an LLIN. 
The second insight relates to how behaviours of different subsets of the human 
population directly impact the personal protection of LLINs. Over the three-year 
study period in paper 3111, true protective efficacy of LLINs decreased more in 
younger age groups than older age groups. Older individuals were largely 
outside until 10pm, and they therefore experienced a significant amount of 
outdoor exposure, both before and after the LLINs and associated changes in 
biting times. However, because younger individuals go to bed earlier, their 
exposure was more heavily influenced by the change in biting time to earlier 
hours. 
Impact of LLINs on disease transmission and prevalence 
Throughout most sites included in these studies, LLINs had the intended impact 
on disease transmission. LLINs contributed to reducing both LF and malaria 
transmission. In the case of LF, the impact on transmission was so great that 
infective L3 larvae were not detected at all during the post-intervention 
period109. This, in addition to the modelling results predicting a high probability 
of transmission cessation in villages with low/moderate endemicity, adds 
significant weight to the recommendation that LLINs should be used in 
combination with MDA to eliminate anopheline-transmitted filariasis138. 
Quantitative analyses and modelling play an important role in achieving the 
elimination goals of many neglected tropical diseases (NTDs)139, and this paper 
demonstrated the potential to use models to predict the likelihood of elimination 
using entomological, rather than epidemiological, indicators. This may be a more 
cost-effective and ethical approach to verify absence of transmission in settings 
of continually decreasing prevalence, as an alternative to taking blood samples 
from young children to identify serological markers of ongoing transmission. 
However, one significant challenge of this strategy is the necessity to fit the 
model to age stratified MF prevalence rates, which are not available in most 
settings84. 
In the case of malaria, EIRs were significantly reduced in the year immediately 
after the net distribution, and in some cases for up to 2 years. It is unclear 
whether the magnitude of change in EIR is sufficient to substantially impact 
parasite prevalence, as the relationship between EIR and parasite prevalence is 
logarithmic140 and large decreases in EIR at the higher range (from 300 or 
greater infective bites/person/night to ~30 infective bites/person/night) result in 
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minimal predicted change in prevalence. EIRs remained at ~10 infective 
bites/person/year after LLINs in most sites. An epidemiological survey conducted 
across the country evaluating the LLIN distribution documented a reduction in 
malaria prevalence in the general population from 15.7% to 4.8%103. However, 
even in those areas where transmission was reduced, sporozoite prevalence 
began to rebound, indicating a substantial amount of residual transmission still 
occurring. Perhaps more worrying was the lack of apparent effect of LLINs on 
malaria prevalence in paper 3111. This lack of impact was associated with a 
change in biting time which resulted in LLINs providing less personal protection. 
Although there is not a causal link between changes in mosquito behaviour and 
the lack of epidemiological impact of LLINs, it is a likely contributor. Another 
factor that was not measured in this study is net durability. It may be that due 
to typical use conditions, nets lose their functionality after 1-2 years, a result 
seen in African settings34. A similar study performed in PNG demonstrated that 
LLINs retain their insecticidal efficacy for 5 years135, however while physical 
durability was measured in this study, it was not incorporated into an overall 
estimation of functional net survival times. 
Complementary, integrated control measures to increase the 
likelihood of LF elimination 
Despite 5 years of MDA in the PNG study villages from 1994 to 1998, paper 1109 
demonstrated that LF was not eliminated. This was evident by an ATP of up to 
325 L3 inoculated per person per year prior to the LLIN distribution. This may 
have been a result of several factors, including migration of infected individuals 
into the communities82, or the inability of MDA to surpass the MF positivity 
threshold (<1%) thought to lead to the absence of transmission30. The 
difficulties in achieving LF elimination despite sustaining high coverage for more 
than 5 years have been experienced elsewhere85,141–143. 
The studies presented in papers 1109 and 4112 of this thesis provide strong 
evidence that additional elimination tools exist that could effectively compliment 
current strategies to achieve global LF elimination goals. First, mathematical 
modelling in paper 1109 predicted a high probability of LF transmission extinction 
in several villages due to LLINs alone. This finding has also been corroborated by 
a similar study in Nigeria144. LLINs could therefore work synergistically with MDA 
in areas with anopheline-transmitted LF, as long as they are able to keep biting 
rates low until adult worms die. These results call for greater integration 
between malaria and LF control programmes, which often work independently of 
one another. 
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Second, IDA eliminated MF from the blood rapidly and for up to two years post-
treatment, which is a significant improvement on previous drug regimens. 
Although IDA may not be able to be implemented everywhere due to areas of 
sub-Saharan Africa co-endemic for onchocerciasis and loiasis, it could still be a 
valuable tool to increase the attainability of LF elimination goals. Although the 
study presented in this thesis was only powered to assess safety and drug 
interactions, the preliminary results are promising, and warrant conducting 
large-scale clinical trials to assess efficacy. If the long-term MF clearance is due 
to embryostatic or embryocidal effects on adult worms, it will be important to 
assess how long-lasting this effect is. Likewise, scrotal ultrasound145 may help to 
determine if IDA has adult worm killing activity.  
Significance and Impact 
The studies included in this thesis have contributed significantly to furthering 
knowledge on control of the vector-borne diseases malaria and lymphatic 
filariasis. In addition, they have resulted in changes in policy recommendations 
at the global level that could see strategies for elimination shift entirely. 
Paper 1109 was the first to predict, using both empirical data and modelling, that 
LLINs have the ability to stop LF transmission entirely. This provided strong 
evidence to support integrated vector management (IVM) strategies between LF 
and malaria programmes, and has been cited in the WHO IVM handbook146. 
Paper 3111 was the first  study to associate shifts in mosquito biting times likely 
caused by LLINs with contemporaneous estimates of malaria burden. This is 
significant, as global policy makers continually express the need to use 
epidemiological, rather than entomological, outcomes as evidence on which to 
base decisions. This is likely to highlight behavioural resistance as a challenge 
worthy of global attention. Finally, paper 4112 was the first to document the 
impact of IDA therapy on sustained suppression of microfilaremia in patients 
with LF. This work has stimulated significant additional funding to support large-
scale clinical trials across 6 countries globally147,148. In addition, modelling 
studies using the data collected in this study predict that the IDA strategy could 
have a transformative impact on the global LF elimination effort149,150. In sub-
Saharan Africa, using the current strategy of MDA and vector control, only 3 out 
of 36 countries will meet the target of eliminating LF by 2020, with 7 more 
before 2030, and the rest after that. Replacing standard MDA with IDA changes 
the picture entirely: 4 will achieve the 2020 target, and all countries will achieve 
elimination by 2025, with the median year being 2021150. As such, IDA is 
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currently recommended as the best regimen in areas not co-endemic for 
onchocerciasis151, and there is strong momentum to perform additional safety 
trials in onchocerciasis endemic areas152, given that the disease is on the decline 
and the likelihood of serious adverse events is waning. 
Vector-borne disease control is at a crossroads. Many NTDs, like LF, are targeted 
for elimination. As prevalence declines, it will be important to tailor and continue 
to invest in control efforts to sustain the gains made already. For malaria, it is 
now well established that elimination will not be attainable without integrated 
vector control measures being applied using relevant evidence to inform 
decisions. These situations necessitate an abundance of high-quality research 
that is able to inform policy decisions. However, the ability to implement finely 
tailored control strategies, even with the relevant evidence, is hindered by 
numerous challenges, many of which are outside the purview of national 
programmes. A complex research-to-policy process slows down access to 
potentially cost-effective and equitable interventions153. Decisions are highly 
influenced by financing mechanisms, and global donor agencies therefore retain 
a large amount of power over which control strategies are implemented. 
Requiring that many different tailored strategies be approved by a global body is 
unrealistic, and therefore a certain amount of decision-making power must be 
transferred back to the countries that the interventions benefit. The capacity to 
make these decisions must therefore be bolstered, and analytical tools to assist 
in decision-making processes must be developed154.    
This body of work has contributed significant new insights that have already 
influenced the research and policy agendas for vector-borne disease control. 
However, further work is clearly needed to identify and evaluate potential vector 
control tools that could potentially overcome some of the challenges associated 
with behavioural resilience identified in this thesis. Tools such as ivermectin-
treated animals155 and transfluthrin emanators156 show promise and could be 
beneficial in areas like PNG where pigs are commonly kept around human 
settlements157 and where a large proportion of biting occurs outdoors and on 
non-human hosts8. A single treatment with IDA has recently been shown to be 
non-inferior to standard annual treatment with ALB and DEC in PNG for up to 
three years158. In addition, better diagnostics for Loa loa159 and sophisticated 
mapping studies160 may make it possible to better target IDA and other 
treatment strategies that are tailored to the local context. However, further work 
is needed to assess the operational feasibility of this approach. 
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Background
Global efforts to eliminate lymphatic filariasis are based on the annual mass ad-
ministration of antifilarial drugs to reduce the microfilaria reservoir available to 
the mosquito vector. Insecticide-treated bed nets are being widely used in areas in 
which filariasis and malaria are coendemic.
Methods
We studied five villages in which five annual mass administrations of antifilarial 
drugs, which were completed in 1998, reduced the transmission of Wuchereria ban-
crofti, one of the nematodes that cause lymphatic filariasis. A total of 21,899 anoph-
eles mosquitoes were collected for 26 months before and 11 to 36 months after bed 
nets treated with long-lasting insecticide were distributed in 2009. We evaluated the 
status of filarial infection and the presence of W. bancrofti DNA in anopheline mos-
quitoes before and after the introduction of insecticide-treated bed nets. We then 
used a model of population dynamics to estimate the probabilities of transmission 
cessation.
Results
Village-specific rates of bites from anopheline mosquitoes ranged from 6.4 to 61.3 
bites per person per day before the bed-net distribution and from 1.1 to 9.4 bites for 
11 months after distribution (P<0.001). During the same period, the rate of detec-
tion of W. bancrofti in anopheline mosquitoes decreased from 1.8% to 0.4% 
(P = 0.005), and the rate of detection of filarial DNA decreased from 19.4% to 14.9% 
(P = 0.13). The annual transmission potential was 5 to 325 infective larvae inoculated 
per person per year before the bed-net distribution and 0 after the distribution. 
Among all five villages with a prevalence of microfilariae of 2 to 38%, the probabil-
ity of transmission cessation increased from less than 1.0% before the bed-net dis-
tribution to a range of 4.9 to 95% in the 11 months after distribution.
Conclusions
Vector control with insecticide-treated bed nets is a valuable tool for W. bancrofti 
elimination in areas in which anopheline mosquitoes transmit the parasite. (Funded 
by the U.S. Public Health Service and the National Institutes of Health.)
The New England Journal of Medicine 
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L
ymphatic filariasis is a parasitic-
worm infection caused by Wuchereria ban-
crofti, Brugia malayi, and B. timori that affects 
approximately 120 million people in Africa, Asia, 
the Pacific, and the Americas.1 Adult filarial 
worms live in the lymphatic system, causing lymph-
edema of the limbs, elephantiasis, and hydrocele. 
Fecund adult female worms release micro filariae, 
which ultimately enter the bloodstream, where 
they are ingested by anthropophilic mosquitoes 
of various genera. Microfilariae develop through 
several stages in mosquito vectors until they be-
come infective larvae (L3), which continue trans-
mission by establishing infection in humans 
through the bite site created during blood feed-
ing. Safe, single-dose, inexpensive drug regimens 
have been developed that significantly reduce 
blood loads of microfilariae in humans for more 
than a year. For this reason, lymphatic filariasis 
has been targeted for global elimination by the 
year 2020 on the basis of annual mass adminis-
tration of single-dose albendazole combined with 
either ivermectin or diethylcarbamazine for 5 or 
more years, the estimated reproductive life span 
of adult worms, which is anticipated to break the 
transmission of lymphatic filariasis from hu-
mans to mosquitoes.2,3
Although this effort has had successes, in-
cluding the distribution of drugs to 570 million 
people in 48 countries,4 it is faced with several 
challenges.5 Annual treatment of at least 80% of 
eligible persons is key to elimination, but this level 
of population coverage has proved to be difficult to 
achieve in some areas because of health-system 
constraints6 and human migration.7 Financial and 
political limitations constrain the sustainability 
of control programs for lymphatic filariasis,8 and 
there is the possibility of drug resistance develop-
ing in the parasite population.9 Finally, elimination 
thresholds are site-specific and unknown in most 
areas.10-12 Therefore, program managers in coun-
tries in which lymphatic filariasis is endemic may 
lack the evidence necessary to make informed deci-
sions regarding whether to conclude, continue, or 
reinstitute mass drug-administration campaigns.
Heterogeneities in elimination thresholds for 
lymphatic filariasis are due largely to differences 
in vector–parasite relationships. In anopheline 
mosquitoes, the proportion of microfilariae that 
develop to become infective larvae decreases as 
the number that are ingested decreases, making 
this vector less efficient as the microfilaria res-
ervoir diminishes, whereas the converse occurs 
in lymphatic filariasis transmitted by culicine 
mosquitoes.13 In both systems, a decrease in the 
rate of mosquito bites will increase the worm 
breakpoint (i.e., the threshold below which the 
prevalence of microfilariae spontaneously moves 
to zero).10 Therefore, the elimination of lymphatic 
filariasis becomes more attainable if vector con-
trol accompanies mass drug-administration cam-
paigns. Elimination end points may also be af-
fected by differences in local endemicity, infection 
aggregation, and the magnitude of acquired im-
munity.10 For example, the worm breakpoint has 
been estimated to differ among neighboring vil-
lages in Papua New Guinea, where Anopheles punctu-
latus is the primary vector.11 These difficulties 
suggest that a uniform global strategy for perma-
nent cessation of transmission of lymphatic fila-
riasis may not be resilient and that a lack of vector 
control may hinder progress toward this goal.14
The possibility of including vector control as 
part of programs to eliminate lymphatic filariasis 
has received increased attention.15,16 In sub-Saha-
ran Africa and Papua New Guinea, where anoph-
eles species transmit both W. bancrofti and malaria, 
there is the opportunity to integrate the elimina-
tion of lymphatic filariasis with national malaria-
control programs in which vector interventions 
are an essential component.17 Observations made 
during malaria-eradication efforts in the Solomon 
Islands from 1974 through 1977 support the effi-
cacy of vector control, since indoor residual spray-
ing with insecticides decreased the prevalence of 
microfilariae from 22% to 0% without the use of 
antifilarial drugs.18 Currently, the most widely 
implemented vector intervention used by malaria-
control programs is universal coverage with insec-
ticide-treated bed nets. However, only one study in 
Kenya has examined the effect of conventional 
permethrin-impregnated nets on W. bancrofti trans-
mission by anophelines,19 and there are no data 
that quantify how the use of bed nets treated 
with long-lasting insecticide will complement the 
mass administration of anti filarial drugs in re-
ducing transmission of lymphatic filariasis and 
the probability of cessation of transmission.
We measured the transmission of lymphatic 
filariasis in five villages in the East Sepik Prov-
ince of Papua New Guinea before and after a 
nationwide bed-net distribution effort in 2009. 
Communities in this area had received the last 
of five annual treatments with antifilarial drugs 
The New England Journal of Medicine 
Downloaded from nejm.org on August 21, 2013. For personal use only. No other uses without permission. 
 Copyright © 2013 Massachusetts Medical Society. All rights reserved. 
Insecticidal Bed Nets and Filariasis Tr ansmission
n engl j med 369;8 nejm.org august 22, 2013 747
more than 10 years earlier (1998) with no subse-
quent interventions until 2009. Since entomologic 
and human-infection data from this earlier time 
were available,20 we were able to compare mass 
drug administration alone and the distribution of 
insecticide-treated bed nets alone with respect to 
the effect on the rate of transmission of lymphatic 
filariasis in the same region.
Me thods
Study Area
Lymphatic filariasis is highly endemic in Papua 
New Guinea, where it is estimated that 4.4 million 
of the country’s 6.3 million residents live in areas 
that qualify for disease elimination.21 We selected 
five villages in the Ambunti-Dreikikir District of 
East Sepik Province for entomologic surveys and 
quantification of the prevalence of microfilariae 
(Fig. 1). Transmission of lymphatic filariasis in 
these villages has been well characterized.20,22-24
We present our findings in the context of his-
torical endemicity levels on the basis of annual 
transmission potentials (the number of infective 
larvae that were inoculated per person per year), 
which were measured before a trial of mass ad-
ministration of antifilarial drugs conducted from 
1993 through 1998.22
Study Participants
Mosquito collectors and village residents who par-
ticipated in surveys of the prevalence of microfi-
lariae and bed nets provided written informed 
consent after protocols were approved by the in-
stitutional review boards at University Hospitals 
Case Medical Center in Cleveland, the Institute of 
Medical Research, and the Medical Research Ad-
visory Committee in Papua New Guinea.
Prevalence of Microfilariae
We measured the prevalence of microfilariae in 
2008, before the distribution of insecticide-treat-
ed bed nets, by counting the number of microfi-
lariae in a 1-ml sample of nocturnally collected 
venous blood after passing it through a 5-µm poly-
carbonate filter.
Mosquito Collection and Analysis
Mosquitoes were collected monthly after landing 
on human adult collectors from July 2007 through 
July 2010. The collectors sat outdoors within sev-
eral meters of the household entrance from 6 p.m. 
to 6 a.m. with their lower legs and feet exposed. 
Collectors worked in teams, with one member 
collecting from 6 p.m. to midnight and the other 
from midnight to 6 a.m. Mosquitoes landing in 
search of a blood meal were captured with an 
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Figure 1. Location of Study Villages in East Sepik Province, Papua New Guinea.
The New England Journal of Medicine 
Downloaded from nejm.org on August 21, 2013. For personal use only. No other uses without permission. 
 Copyright © 2013 Massachusetts Medical Society. All rights reserved. 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 369;8 nejm.org august 22, 2013748
aspirator and stored according to the hour they 
were collected. Each village was divided into four 
hamlets, with monthly collections in each ham-
let. The total effort each month varied from 40 to 
48 collection nights. Mosquitoes were morpho-
logically identified as A. punctulatus, A. koliensis, or 
A. farauti sensu lato, according to criteria established 
previously,25 and were stored according to species, 
location, and hour collected. Half the mosquitoes 
were stored in 70% ethanol for later dissection 
and the other half on silica gel for DNA diagnostic 
evaluation, as described below. A total of 10,578 
mosquitoes were stained individually with Mayer’s 
hemalum,26 separated into body sections on a glass 
slide, and dissected with forceps and needles un-
der a microscope. Dissected specimens were ex-
amined for W. bancrofti in the infective larval 
stage and other developing larval stages (L1 and 
L2) with the use of standard criteria.27
Genomic DNA was extracted from unfed dried 
mosquitoes singly or in pools of two (Qiagen). 
Identification of the species of 2867 mosquitoes 
was confirmed with the use of polymerase-chain-
reaction (PCR) amplification of the internal tran-
scribed spacer 2 region of mosquito ribosomal 
DNA and either digested with MSP1 enzyme28 or 
used in a ligase detection reaction–fluorescent 
microsphere assay.29 A total of 1009 samples were 
also screened for W. bancrofti DNA by PCR ampli-
fication of the long DNA repeat region to be used 
as a xenomonitoring tool.30
At the close of the study, one village with a 
moderate transmission level (Nanaha) and one 
with a high transmission level (Yauatong) were se-
lected for long-term assessment of rates of mos-
quito biting. Mosquito collections were conducted 
quarterly in the second and third year after the 
bed-net distribution.
Insecticide-Treated Bed Nets
PermaNet 2.0, an insecticide-treated bed net im-
pregnated with 55 mg of deltamethrin per square 
meter (Vestergaard Frandsen), was distributed to 
study communities by the East Sepik Province 
Division of Health in August 2009. At that time, 
the national target for bed-net coverage was 80% 
of household ownership and 80% use for chil-
dren under the age of 5 years and for pregnant 
women. Surveys regarding bed-net use were con-
ducted in November 2008 and again in Septem-
ber through December 2009 by asking adults 
(≥18 years of age) and parents or guardians of 
children if they had slept under a bed net the 
previous night.
Statistical Analysis
We estimated the daily mosquito-biting rates on 
the basis of the mean number of host-seeking 
anopheline mosquitoes that were collected in a 
12-hour period. We calculated annual transmission 
potentials by multiplying the mean daily biting 
rate in the community by 365, which was then 
multiplied by the proportion of bites that were 
infective and by the mean number of L3 larvae per 
infective bite. We used the Mann–Whitney U test 
to compare biting rates before and after bed-net 
distribution and Fisher’s exact test to compare 
rates of mosquito infection and infectivity before 
and after bed-net distribution. All statistical analy-
ses were performed with the use of PASW Statis-
tics, version 17.0.3 (IBM).
We used a numerical-modeling and Bayesian 
analysis method that was based on the mosqui-
to-biting rate and the prevalence of microfilari-
ae, stratified according to the age of residents in 
the 2008 survey, to estimate the likelihood of 
transmission cessation before and after bed-net 
distribution.10,11 (Details are provided in the Sup-
plementary Appendix, available with the full text 
of this article at NEJM.org.)
R esult s
Prevalence of Human Infection
Descriptive characteristics of the study popula-
tion20 are summarized in Table 1. In 2008, the 
prevalence of microfilariae in the three study vil-
lages in the high-transmission zone ranged from 
23.7% to 38.6%. These values were significantly 
higher than in 1998, when the values ranged 
from 3.7 to 10.8% (P<0.001 by Fisher’s exact test), 
1 year after the fourth annual mass administra-
tion of antifilarial drugs and immediately before 
the fifth and final mass treatment. In contrast, 
the prevalence of microfilariae in the two villag-
es in the moderate-transmission zone, Nanaha 
and Ngahmbule, remained low and did not change 
significantly during the 10-year period, with prev-
alences of 3.4% or less in both villages in 2008 
(P = 0.78 and P = 0.39, respectively, for comparisons 
with 1998 values). Notably, the prevalence of mi-
crofilariae in 2008 did not increase in any of the 
villages to the level in 1994, before mass drug 
administration (Table 1).
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Use of Insecticide-Treated Bed Nets
Immediately before bed-net distribution, 3.8% 
and 12.4% of households of the two study vil-
lages surveyed used bed nets of any type. Four to 
5 months after distribution, self-reported house-
hold use of bed nets in the five study villages 
ranged from 75.0 to 90.6% (Table 1).
Mosquito Vectors
A total of 20,345 anopheline mosquitoes were 
collected in the 26 months before bed-net distri-
bution and 1554 in the 11 months after distribu-
tion. The subgroups of mosquitoes in which the 
species was confirmed included 78% of A. punctu-
latus and 21% of A. koliensis; the remaining 1% was 
a mix of A. hinesorum, A. farauti 4, and A. farauti sensu 
stricto. Among A. koliensis mosquitoes, 94% were 
caught in Nanaha and Ngahmbule; molecular 
confirmation of the morphologic identification of 
A. punctulatus resulted in 95% concordance. Only 
mosquitoes that were identified as A. punctulatus 
on morphologic analysis harbored W. bancrofti in-
fective larvae. Subsequent data are therefore 
based on morphologically identified A. punctulatus.
The proportion of A. punctulatus mosquitoes 
that were infected with any stage of larvae de-
creased from 1.8% to 0.4% after bed-net distri-
bution (P = 0.005 by Fisher’s exact test) (Fig. 2). 
None of the mosquitoes that were collected in 
Peneng, Nanaha, or Ngahmbule after bed-net dis-
tribution contained larvae of any stage. Notably, 
no mosquitoes harboring infective larvae were 
identified in any of the villages after bed-net 
distribution (P = 0.07 by Fisher’s exact test). There-
fore, although annual transmission potentials 
were similar during each of the 2 years preced-
ing bed-net distribution, that number dropped 
to zero for the year after bed-net distribution 
(Fig. 3). The proportion of anopheline mosquitoes 
that tested positive for W. bancrofti DNA, an indi-
cator of the reservoir of microfilariae, was 19.4% 
(761 mosquitoes) before bed-net distribution and 
14.9% (248 mosquitoes) after bed-net distribu-
tion (P = 0.13 by Fisher’s exact test).
Mosquito-Biting Rates
The daily biting rates for anopheline mosquitoes 
decreased significantly after bed-net distribution, 
with a mean (±SE) of 61.3±4.9 bites per person 
per day before bed-net distribution versus 9.4±1.9 
after bed-net distribution in Yauatong, 22.6±2.5 
versus 7.3±2.0 in Albulum, 6.4±0.8 versus 1.5±0.4 
in Peneng, 21.5±1.3 versus 1.1±0.2 in Nanaha, 
and 8.9±0.8 versus 1.5±0.3 in Ngahmbule (P<0.001 
for all comparisons by the Mann–Whitney U test). 
The rates remained consistently low for an addi-
tional 2 years in Yauatong and Nanaha (Fig. 4).
The probability of the transmission cessation 
was less than 1.0% in all five villages before 
bed-net distribution. After bed-net distribution, 
the probabilities increased to 4.9%, 7.7%, 90.5%, 
95.8%, and 61.5% in Yauatong, Albulum, Peneng, 
Nanaha, and Ngahmbule, respectively. Further 
reductions in biting rates by years 2 and 3 after 
bed-net distribution increased the probabilities 
to 36.8% and more than 99% in Yauatong and 
Nanaha, respectively. These high probabilities pro-
vide support for the empirical finding that an-
nual transmission potentials were reduced to 
zero after bed-net distribution (Fig. 2).
Table 1. Status of Lymphatic Filariasis and Use of Insecticide-Treated Bed Nets in the Study Villages.*
Level of 
Transmission
Village 
Name Microfilariae Prevalence
Population
of Village
Bed-Net Use before 
Distribution in 2009
Bed Nets
Distributed
Bed-Net Use after 
Distribution
1994 1998 2008
% no. % no. %
High Yauatong 79.5 10.8 38.6 408 12.4 190 84.3
High Albulum 78.3 7.4 38.4 526 NA 234 81.7
High Peneng 61.5 3.7 23.7 233 3.8 142 75.0
Moderate Nanaha 48.3 2.4 2.0 507 NA 222 84.1
Moderate Ngahmbule 36.2 1.7 3.4 256 NA 109 90.6
* Transmission levels are based on annual transmission potentials determined in 1993 and 1994. Five annual mass antifilarial treatments 
consisting of diethylcarbamazine alone or diethylcarbamazine plus ivermectin were administered from 1994 through 1998. (This regimen 
differed from the standard treatment in the global program to eliminate lymphatic filariasis.) Insecticide-treated bed nets were distributed in 
August 2009, with a target coverage of at least 80% of households per village. NA denotes not available.
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Discussion
Residents of villages in our study participated in 
a 5-year program of mass administration of anti-
filarial drugs, with 77 to 86% of eligible residents 
receiving such drugs annually from 1994 through 
1998.20 The prospect of the elimination of lym-
phatic filariasis was promising at the end of the 
campaign and seemed even more likely after a 
2003 survey showed very few mosquitoes contain-
ing developing larvae, no mosquitoes containing 
infective larvae, and no children under the age of 
10 years who tested positive for filarial antigen.24 
However, it is clear from observations in 2008 
and 2009 that transmission was still occurring, 
since annual transmission potentials among the 
study villages ranged from 5 to 325 infective lar-
vae that were inoculated per person per year, and 
the prevalence of microfilariae had significantly 
rebounded in three villages. Human migration 
may have contributed to continuing transmission 
and increased prevalence of microfilariae after 
the cessation of mass treatment.31 The fact that 
worm breakpoints that were necessary for the ces-
sation of transmission were not attained is prob-
ably of greater importance. In 1997, after four 
annual mass drug administrations, the prevalence 
of microfilariae in moderate- and high-transmis-
sion zones was 1% and 5%, respectively.20 How-
ever, worm breakpoints for anopheline systems 
are estimated to be 0.75%.11
The introduction of insecticide-treated bed nets 
profoundly affected the vector population and 
therefore the transmission of lymphatic filariasis. 
A similar proportion of mosquitoes tested posi-
tive for W. bancrofti DNA before and after bed-net 
distribution. However, significantly fewer mos-
quitoes contained developing worms after bed-
net distribution. These findings indicate that 
mosquitoes were imbibing microfilaremic blood, 
but larval development was interrupted. The use 
of bed nets may reduce the transmission of vec-
torborne diseases by shortening the life span of 
mosquitoes,32 and W. bancrofti microfilariae re-
quire at least 13 days to develop into infective 
larvae in A. punctulatus.33 Therefore, a slight re-
duction in average life span could have a major 
effect on the number of infective larvae. In addi-
tion, after the introduction of bed nets, most 
mosquitoes that fed successfully probably were 
feeding before residents went to bed. We saw 
that a greater proportion of the mosquito popu-
lation was biting at earlier hours after bed nets 
were introduced. Because of the nocturnal peri-
odicity of microfilaremia in Papua New Guinea, 
earlier biters will ingest fewer microfilariae than 
those biting during the time of peak blood den-
sity of microfilariae (around 1:30 a.m.) (Fig. S1 
in the Supplementary Appendix).
Previous studies have shown how vector con-
trol alone can be used to reduce the prevalence 
of microfilariae34 and to accelerate this decrease 
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when combined with mass administration of an-
tifilarial drugs.35,36 However, our study quanti-
fies the effect of the most widely implemented 
vector-control measure, the use of insecticide-
treated bed nets. Although vector control is not 
currently a part of the global strategy to eliminate 
lymphatic filariasis, universal bed-net distribution 
is now used widely for malaria control-and-elim-
ination efforts in Papua New Guinea and sub-
Saharan Africa. Thus, our study highlights the 
importance of integrating vectorborne disease 
interventions. However, in order for the use of 
bed nets to be a sustainable strategy to eliminate 
lymphatic filariasis, biting rates must remain be-
low the threshold until lymphatic-dwelling adult 
worms in the population die. The likelihood of 
transmission cessation that we observed is a 
snapshot of a temporally dynamic transmission 
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system. A small increase in biting rate with no 
change in human prevalence of microfilariae 
could quickly lead to a reestablishment of stable 
transmission.
Program managers wanting to determine trans-
mission end points during elimination campaigns 
are met with the challenge of detecting human 
infection at progressively lower levels.37 In our 
study, we used data on the prevalence of micro-
filariae before the intervention and a model of 
the transmission of lymphatic filariasis to quan-
tify the probability of transmission cessation on 
the basis of mosquito-biting rates alone. Annual 
transmission potentials dropped to zero after bed-
net distribution in all villages on the basis of an 
absence of infective larvae in blood-seeking mos-
quitoes, though detection of infective mosquitoes 
was constrained by very low vector densities. The 
probability of transmission cessation was more 
than 50% in the two moderate-transmission vil-
lages, where the prevalence of microfilariae was 
3.4% or less before bed-net distribution. A simi-
lar likelihood of transmission cessation was 
calculated for Peneng, where the prevalence of 
microfilariae in 2008 was 23.7%, but the mos-
quito-biting rate was similar to rates in the moder-
ate-transmission villages after bed-net distribution.
If the use of bed nets remains high and vector 
populations continue to be susceptible, the use 
of bed nets may eliminate lymphatic filariasis in 
areas where the reservoir of microfilariae has 
first been reduced by mass drug administration, 
as in the populations included in this study, or 
where preintervention endemicity is already low, 
such as in the Solomon Islands.18 In high-trans-
mission areas, the use of bed nets could work 
synergistically with mass drug administration by 
increasing the worm breakpoint to a more easily 
attainable level. Given the challenges of reaching 
80% compliance with mass drug administration 
for at least 5 years,38,39 efforts to eliminate lym-
phatic filariasis would greatly benefit from inte-
grated vector management.40
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Abstract 
Background: The major malaria vectors of Papua New Guinea exhibit heterogeneities in distribution, biting behav-
iour and malaria infection levels. Long-lasting, insecticide-treated nets (LLINs), distributed as part of the National 
Malaria Control Programme, are the primary intervention targeting malaria transmission. This study evaluated the 
impact of LLINs on anopheline density, species composition, feeding behaviour, and malaria transmission.
Methods: Mosquitoes were collected by human landing catch in 11 villages from East Sepik Province and Madang 
Province. Mosquitoes were collected for 3 years (1 year before distribution and 2 years after), and assayed to deter-
mine mosquito species and Plasmodium spp. infection prevalence. The influence of weather conditions and the 
presence of people and animals on biting density was determined. Determinants of biting density and sporozoite 
prevalence were analysed by generalized estimating equations (GEE).
Results: Mosquito biting rates and entomological inoculation rates decreased significantly after the distribution. 
Plasmodium falciparum and P. vivax sporozoite prevalence decreased in year 2, but increased in year 3, suggesting the 
likelihood of resurgence in transmission if low biting rates are not maintained. An earlier shift in the median biting 
time of Anopheles punctulatus and An. farauti s.s. was observed. However, this was not accompanied by an increase in 
the proportion of infective bites occurring before 2200 hours. A change in species composition was observed, which 
resulted in dominance of An. punctulatus in Dreikikir region, but a decrease in An. punctulatus in the Madang region. 
When controlling for village and study year, An. farauti s.s., An. koliensis and An. punctulatus were equally likely to carry 
P. vivax sporozoites. However, An. punctulatus was significantly more likely than An. farauti s.s. (OR 0.14; p = 0.007) or 
An. koliensis (OR 0.27; p < 0.001) to carry P. falciparum sporozoites.
Conclusions: LLINs had a significant impact on malaria transmission, despite exophagic and crepuscular feeding 
behaviours of dominant vectors. Changes in species composition and feeding behaviour were observed, but their 
epidemiological significance will depend on their durability over time.
Keywords: Anopheles punctulatus, Anopheles farauti, Anopheles kolienses, Malaria, Papua New Guinea, Bed nets, LLIN
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Background
Malaria transmission in Papua New Guinea (PNG) is 
highly variable across environmentally diverse zones, 
ranging from intense perennial transmission in the north-
ern coastal lowlands to seasonal moderate transmission 
in the southern coast and unstable transmission at higher 
altitudes [1]. A recent survey reported weighted malaria 
parasite prevalence of 12  % nationwide, with substantial 
heterogeneity, ranging from 0 to 49.7 % [2]. Four malaria 
species are endemic to PNG (Plasmodium falciparum, P. 
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ivax, P. ovale, and P. malariae) with the majority of infec-
tions caused by P. falciparum and P. vivax [3, 4]. he major 
malaria and ilariasis vectors in PNG are members of the 
Anopheles punctulatus group. his group comprises 13 
species, each exhibiting diferent degrees of exophily and 
anthropophily and diferent habitat preferences [5–8]. 
he ive major malaria vectors in this group, due to their 
widespread distribution and high abundance, include An. 
punctulatus, An. farauti s.s., An. koliensis, An. hinesorum, 
and An. farauti 4 [5]. In addition to the Anopheles punctu-
latus group, An. bancroftii, An. longirostris, An. karwari, 
and An. subpictus have been incriminated as malaria 
vectors.
Prior to the development of more sensitive molecu-
lar diagnostics in the 1990s [9–11], identiication was 
restricted to the Punctulatus clade (now known to 
include An. punctulatus, An. farauti 4 and An. sp. nr 
punctulatus), Farauti clade (now known to include An. 
farauti s.s., An. hinesorum, An. torresiensis, An. farauti 5, 
An. farauti 6, and An. farauti 7) and An. koliensis. Mor-
phological identiication, based on proboscis scale pat-
terns and the presence of a sector spot on the costal wing 
vein, was often unreliable in distinguishing An. koliensis 
due to variable scaling patterns, even within isofemale 
lines [12–15].
Although restricted by morphological identiication, 
early studies highlight heterogeneities in habitat prefer-
ence, seasonality, human blood index, and transmission 
potential among members of this complex. Diferences 
were observed in the spatial distribution of species among 
and within villages, larval habitats and vegetation. An. far-
auti s.s. is primarily found in coastal villages with a high 
tolerance for breeding in brackish water. An. farauti s.s. 
and An. hinesorum are more commonly found in natural 
breeding sites, such as ground pools, while An. punctula-
tus is commonly found in areas disturbed by human activ-
ity [14, 16]. An. punctulatus is abundant in the hills and 
An. koliensis has a patchy distribution in lowland inland 
areas [17], and both exploit diferent larval habitats [18]. 
Abundance is correlated with recent rainfall, with An. 
koliensis showing greater temporal variability than An. 
punctulatus and An. farauti s.l. Peak outdoor biting times 
vary with the majority of An. farauti s.l. biting in the early 
evening and An. koliensis and An. punctulatus biting in 
the late night and early hours of the morning [13].
Pilot projects in PNG in the 1950s demonstrated the 
likelihood that DDT could successfully control malaria 
given the proper resources. It was not until the 1970s, 
through the support of United Nations Development 
Programme, that the DDT indoor residual spraying cam-
paign was scaled up to cover over 50 % of the population 
[19]. In Madang, DDT spraying was inefective against 
An. farauti s.l., but very efective against An. punctulatus 
and moderately efective against An. koliensis [17]. In the 
Solomon Islands, DDT residual spraying impacted mem-
bers of the complex diferently [20, 21] with a stronger 
impact on An. punctulatus and An. koliensis than An. far-
auti s.s.
Long-lasting, insecticide-treated nets (LLINs) can be a 
powerful tool in reducing malaria-associated morbidity, 
particularly when high community coverage is achieved 
[22]. In PNG, where the vector population is 100 % sus-
ceptible to pyrethroids [23] LLINs remain efective for 
up to 5 years of in-home use [24], and are an attractive 
choice for malaria control. However, the tendency of the 
vector population to spend the majority of time outdoors 
[17] may render them less susceptible to indoor vec-
tor control due to low biological coverage. Furthermore, 
home-based interventions may have an unequal impact 
in areas with multiple vector species exhibiting a range of 
exophily and anthropophily.
he PNG Malaria Control Programme, supported by 
the Global Fund to Fight AIDS, Tuberculosis and Malaria, 
launched a countrywide, free, LLIN distribution between 
2005 and 2009. PermaNet 2.0 LLINs, treated with 55 mg/
cu m deltamethrin and manufactured by Vestergaard 
Frandsen, were distributed at a target ratio of one net per 
2.5 household members. Independent household surveys 
reported 68.7 % of households surveyed in the Momase 
region (Morobe, Madang and Sepik Provinces included 
in this study) owned at least one LLIN (with 47 % sleep-
ing underneath a LLIN the night before), while 95  % of 
households had at least one net of any type (with 74  % 
sleeping underneath the night before) [25]. In addition, 
the malaria control programme introduced rapid diag-
nostic tests and artemisinin-based combination therapy 
in 2012 [26].
he purpose of this study was to determine the impact 
of the LLIN distribution on mosquito abundance, species 
composition, peak biting times, and malaria transmission 
in three geographical regions of PNG with multiple, sym-
patric vector species.
Methods
Study villages
Eleven villages, covering three geographic regions, were 
included in the study (Fig.  1). Coastal villages are char-
acterized by coconut plantations and swamps while the 
inland foothills (Madang and Dreikikir) are characterized 
by thick vegetation. Houses are typically built on stilts 
from bamboo or sago palm with a large open veranda. 
July, August and September experience lower rainfall but 
there is no pronounced dry season. Climate, topography 
and larval sites have been described elsewhere [14].
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Experimental design
Mosquitoes were collected by the outdoor human land-
ing catch method for 1 year prior to and 1 year following 
the nationwide LLIN distribution. Four representative vil-
lages (Matukar, Dimer, Nanaha, Yauatong) were chosen 
for further surveillance throughout year 3. Collectors were 
trained to aspirate host-seeking mosquitoes before biting in 
order to minimize exposure to malaria. Pairs of collectors 
worked in teams, with one individual collecting all mosqui-
toes landing on exposed legs from 1800 to 2400 hours and 
the second individual collecting from 24.00 to 06.00. he 
collectors rotated from the early shift to the late shift on 
subsequent nights. Mosquitoes were stored in cups accord-
ing to the date, location and hour of collection. Following 
morphological identiication [27, 28], mosquitoes were 
stored dry on silica gel and returned to the laboratory for 
mosquito species conirmation and enzyme-linked immu-
nosorbent assay to detect Plasmodium spp. circumsporo-
zoite protein. In the Madang villages, additional data were 
recorded hourly by each collector, including: the number 
of animals and number of additional people present in the 
hamlet, as well as a qualitative record of wind, rainfall and 
cloud cover (none, light, moderate or heavy).
Collection efort
In both inland and coastal regions of Madang, the irst 
year of mosquito collections began in August 2008 until 
LLINs were distributed in July and August 2009. Year 
2 collections began after LLIN distribution through 
September 2010, and year 3 collections concluded in 
November 2011. In the Dreikikir region, the irst year of 
collections began in September 2008 until LLINs were 
distributed in late August 2009. Year 2 collections contin-
ued until July 2010 and year 3 collections concluded in 
July 2011. Mosquitoes were collected monthly in every 
village for the irst 2 years. In the third year, collections 
occurred only in select villages with bimonthly collec-
tions in Dimer and Matukar and quarterly collections 
in Nanaha and Yauatong. Details of collection efort per 
year are shown in Additional ile 1: Table S1.
Molecular diagnostics
Mosquitoes that were morphologically identiied as 
members of the An. punctulatus group were conirmed 
to species by PCR-restriction fragment length polymor-
phism of the ITS2 region (4) using either an individual leg 
or extracted DNA (QIAGEN, Maryland, USA). Lysates 
from whole mosquitoes were screened for P. falciparum, 
P. vivax 210 and P. vivax 247 circumsporozoite proteins 
by enzyme-linked immunosorbent assay [29].
Rainfall data
Rainfall data were collected by the PNG National 
Weather Service from Madang airport, 37–52  km from 
the Madang study villages. Although variations are to be 
expected between inland and coastal villages, regional 
rainfall records demonstrate typical seasonality and a 
lack of aberrant rainfall during the collection period.
Papua New Guinea
MatukarWasab
Garup
Dimer Megiar
Mirap
Ngahmbule
Nanaha
Peneng
Albulum
Yauatong
0
0
0
500 km
20 km
20 km
Dreikikir Region
Madang Region
Fig. 1 Map of study villages. Madang coastal (purple), Madang inland (blue) and Dreikikir (red) field sites
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Ethical approval
his study was approved by the institutional review 
boards at University Hospitals Case Medical Center 
in Cleveland, Ohio, USA and the Institute of Medical 
Research and Medical Research Advisory Council of 
PNG.
Data analysis
Generalized estimating equations (GEE) were used to 
identify the determinants of mosquito abundance and 
infection prevalence. When the dependent variable was 
binary (sporozoite prevalence), a binomial distribution 
with a log link function was used. For count data (mos-
quito abundance), a Poisson distribution with log link 
function was used. In both cases, an exchangeable work-
ing correlation matrix was assumed. For sporozoite prev-
alence, separate models were constructed with either P. 
falciparum or P. vivax positivity as the dependent vari-
able. Mosquito species (only An. punctulatus complex 
members were included) and year of the study (years 1, 
2, 3) were covariates and village was the subject variable. 
For mosquito abundance, LLINs (presence or absence), 
rain in mm the previous month, the number of people 
and animals present outdoors within the compound, and 
the qualitative variables of rain, wind and cloud cover 
were included as covariates. Subject variables were village 
and collector, and within-subject variables were the date 
and hour of collection.
Species composition before and after the distribution 
are presented for the four intensively surveyed villages. 
Due to a signiicant association between P. falciparum 
infection and An. punctulatus, the proportion of this spe-
cies of the total catch between year 1 and years 2 and 3 
was compared by Fisher’s exact test.
Median biting times were calculated based on the 
entire catch of a given species per village and year. Not 
all collected species could be PCR-conirmed, therefore 
only villages that showed 95  % concordance between 
morphological and molecular identiication in a given 
year are presented, and the data include all morpho-
logically identiied species. Mann–Whitney U tests were 
performed to determine if the medians between years 
were the same.
Mean man-biting rates were calculated for each village 
and compared between years 1 and 2 or 1 and 3 (t test 
with Bonferroni correction for multiple comparisons). 
Entomological inoculation rates, a measure of the num-
ber of infective bites per person per year, were calculated 
based on the average total number of bites per person per 
year and the sporozoite prevalence in mosquitoes.
Results
he distribution of LLINs had a signiicant efect on 
anopheline biting density (p  <  0.001, Table  1). In addi-
tion to the presence of LLINs, wind and rain at the time 
of collection were negatively associated with anopheline 
biting density (p < 0.001 and p = 0.046, respectively), as 
was rainfall from the previous month (p = 0.002). Cloud 
cover at the time of collection was positively associated 
with biting density (p = 0.003) although this relationship 
was limited to light cloud cover only. he number of peo-
ple and animals present in the hamlet during the collec-
tion hour did not inluence biting density (p = 0.56 and 
p = 0.80, respectively).
Mean monthly man biting rates for the Madang regions 
are shown in Fig. 2. In both Madang sites, biting densi-
ties peaked in September 2008 and generally declined 
until LLINs were distributed in August 2009. his peak 
corresponds with low rainfall in August following heavier 
rains in June (Fig.  2a). Similar patterns in rainfall were 
observed during all three years; however, after LLINs 
were distributed biting densities remained low (Fig.  2b, 
c).
Anopheles farauti s.s. was the dominant species col-
lected in the coastal villages and An. punctulatus was 
dominant in inland Madang and Dreikikir (Fig.  3). An. 
koliensis was dominant in Nanaha, but only in year 1 
(Fig.  3). In addition to members of the An. punctulatus 
group, An. bancroftii, An. longirostris and An. karwari 
Table 1 The efect of  environmental variables on  hourly 
catch of anopheline mosquitoes
a Categorical variables refer to the conditions during the hour of collection
b Categorical variable referring to whether LLINs had been distributed
c Continuous variables refer to the number of alternative hosts present during 
the hour of collection
d Continuous variable referring to the amount of rainfall in the previous month
Variable Category p value Odds ratio 95 % CI
Winda None 1.00
Light 0.263 0.87 [0.69, 1.11]
Moderate <0.001 0.50 [0.39, 0.66]
Heavy <0.001 0.37 [0.27, 0.52]
Clouda None 1.00
Light 0.001 1.40 [1.14, 1.72]
Moderate 0.245 0.83 [0.60, 1.14]
Heavy 0.890 0.99 [0.83, 1.18]
Raina None 1.00
Light 0.563 1.06 [0.87, 1.30]
Moderate 0.120 0.69 [0.44, 1.10]
Heavy 0.129 0.76 [0.54, 1.08]
LLINsb Absent 1.00
Present <0.001 0.38 [0.29, 0.48]
Peoplec 0.555
Animalc 0.800
Rain_lagd 0.002
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were collected at lower densities. An increase in the 
proportion of An. punctulatus and a decrease in the 
proportion of An. farauti s.s. were observed in both rep-
resentative Madang villages (Matukar: p = 0.0001, Dimer: 
p =  0.0001), while an increase in the proportion of An. 
punctulatus and a decrease in the proportion of An. 
koliensis were observed at both representative Dreikikir 
villages (Yauatong: p = 0.007, Nanaha: p = 0.0001).
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Fig. 2 Madang region monthly rainfall and biting rates. Madang airport monthly rainfall (a) and mean nightly man biting rates in (b) coastal 
Madang (n = 5093), (c) inland Madang (n = 2804). The arrows represent LLIN distribution dates in the community. Each village had a similar 
sampling effort between years 1 and 2 (August 2008–July 2010). However, in year 3 (August 2010–November 2011), only Matukar and Dimer were 
sampled
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Anopheles farauti s.s. had a tendency for earlier bit-
ing compared to An. punctulatus and An. koliensis with 
38, 16 and 15 % biting before 22.00, respectively. Signii-
cant shifts were observed in median biting time after the 
LLIN distribution for An. punctulatus and An. farauti 
s.s. (Fig.  4), with the exception of An. punctulatus from 
Ngahmbule village. Despite this shift, there was no statis-
tically signiicant diference in the proportion of infective 
bites occurring before 22.00 pre-LLIN (42.9 %) compared 
to after LLINs (35 %, Fisher’s exact p = 0.56).
Individual village level analyses showed a signiicant 
reduction in mean annual man biting rates in eight of 
the 11 villages following the LLIN distribution (Fig.  5; 
p  <  0.003). he three remaining villages had the low-
est pre-intervention biting rates per region and they 
exhibited reductions that were non-signiicant (Megiar 
p = 0.11, Garup p = 0.13, Peneng p = 0.009). A reduc-
tion in annual entomological inoculation rate (Fig. 5) was 
observed in all villages except Garup.
GEE analysis indicated that, when controlling for vil-
lage and mosquito species, the chance of a mosquito 
carrying sporozoites in the second year was signiicantly 
lower than the pre-intervention period for both P. fal-
ciparum (OR 0.12; 95 % CI 0.03, 0.51; p = 0.004) and P. 
vivax (OR 0.17; 95 % CI 0.08, 0.36; p < 0.001). In the third 
year, the odds of sporozoite positivity rebounded for both 
P. vivax (OR 0.49; 95 % CI 0.27, 0.87; p = 0.015) and P. 
falciparum (OR 0.74; 95  % CI 0.44, 1.25; p  =  0.261), 
although the probability of carrying P. vivax sporozoites 
was still less than in the pre-intervention period (Addi-
tional ile 2: Table S2). When controlling for village and 
study year, An. farauti s.s., An. koliensis and An. punctula-
tus were equally likely to carry P. vivax sporozoites. How-
ever, An. punctulatus  was signiicantly more likely than 
An. farauti s.s. (OR 0.14; 95 % CI 0.03, 0.58; p =  0.007) 
or An. koliensis (OR 0.27; 95 % CI 0.13, 0.57; p < 0.001) to 
carry P. falciparum sporozoites (Fig. 6).
Discussion
Mosquito populations have been extensively studied in 
Madang and East Sepik Provinces, where P. falciparum 
and P. vivax are both highly endemic. In Dreikikir, pre-
LLIN sporozoite rates and man biting rates were similar 
to those observed in the late 1950s [30]. In Madang Prov-
ince, sporozoite rates are similar to previous studies [13, 
31] but observed man biting rates were lower than his-
torically reported [31, 32].
Overall, man biting rates dropped signiicantly in the 
year following LLIN distribution and remained low 
in representative villages through the third year. Even 
though members of the An. punctulatus group do not 
exhibit preferences for endophagy [17], LLINs may still 
have a large communal impact if LLIN coverage and 
usage is high [33]. LLIN usage in study sites was higher 
than regionally reported [25]. A survey 3 months follow-
ing the distribution in Dreikikir revealed that 79  % had 
slept under a LLIN the previous night [34]. A separate 
survey conducted in Madang study sites 3 years after the 
distribution revealed that 79 % had slept under a LLIN in 
Mirap and 54 % had slept under a LLIN in Wasab (JBK, 
unpublished). A separate study has shown that individual 
LLIN use and high community LLIN coverage were inde-
pendently and strongly associated with reduced odds of 
malaria infection in PNG [2].
Although biting rates decreased, a trend towards earlier 
biting was observed in An. punctulatus and An. farauti 
s.s. Changes in biting behaviour were previously reported 
in An. farauti and An. koliensis, in a nearby village, fol-
lowing distribution of insecticide-treated nets in 1985 
[35]. In PNG, this shift could be indicative of behavioural 
lexibility or the impact of LLINs on population age 
Pre-LLIN 
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Post-LLIN 
Composion
Yauatong
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Matukar
Dimer
An. punctulatus
An. farau s.s.
An. koliensis
An. hinesorum
An. farau 4
An. longirostris
An. karwari
An. bancroii
Fig. 3 Species composition before and after LLIN distribution. PCR 
confirmed anopheline species composition for Matukar (n = 1182 
pre-LLIN, n = 430 post-LLIN), Dimer (n = 1417 pre-LLIN, n = 272 
post-LLIN), Yauatong (n = 722 pre-LLIN, n = 324 post-LLIN), Nanaha 
(n = 738 pre-LLIN, n = 83 post-LLIN)
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structure; it has been observed that nulliparous females 
bite earlier than parous females [36]. he former scenario 
has been suggested in an An. farauti s.l. population in the 
Solomon Islands following a DDT spraying campaign 
[20]. Additional behavioural and genetic studies could 
elucidate whether selection is occurring in populations 
in this study. In the latter scenario, early biting patterns 
would not be accompanied by increased exposure even 
if biting densities returned to pre-control levels. No 
increase in the proportion of infective bites occurring 
before 22.00 in this study was observed, although sample 
sizes were limited. Continued surveillance can determine 
Fig. 5 Man biting rate and entomological inoculation rate. Panels on the left show mean nightly biting rate (± SEM) in villages from each region. 
Asterisk indicates villages which experienced a significant reduction between years 1 (pre-LLIN) and 2 or 3 (post LLIN) (Bonferonni adjusted 
alpha = 0.003). Panels on the right show entomological inoculation rate (infective bites/person/year) with P. falciparum and P. vivax in year 1 (pre-
LLIN), 2 and 3 (post-LLIN) for each region
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if the observed shifts in biting times are epidemiologi-
cally signiicant, and whether they will limit the protec-
tive efect of LLINs.
Diferences in species composition were observed after 
LLIN distribution. However, there was not a consistent 
trend across villages towards species dominance. For 
example, in the Madang villages, An. farauti s.s. increased 
in proportion over An. punctulatus while in Dreikikir, 
An. punctulatus increased in proportion over An. kolien-
sis. It is likely that some species will be more resilient 
to this intervention than others, and changes in species 
composition will depend on behaviour and physiology 
of the entire population. he observed pattern may be 
attributed to a greater impact of LLINs on the later bit-
ing species in the community. he observed increase in 
the proportion of An. punctulatus could be epidemiologi-
cally signiicant given the close association between this 
species and P. falciparum transmission. Further work is 
needed to determine whether these changes in species 
composition are durable, and whether they are associated 
with malaria prevalence.
While LLINs were very efective in reducing man bit-
ing rate and entomological inoculation rate in the three 
regions, sporozoite prevalence did not remain low. he 
observed increase in sporozoite prevalence between 
years 2 and 3 may be attributable to a low sample size, 
a challenge in post-intervention evaluations. However, it 
is clear that residual malaria transmission is still occur-
ring, and that any rebound in mosquito density will be 
accompanied by an increase in transmission intensity. 
In both Madang regions, P. falciparum sporozoite rate 
was higher in year 3 than in year 1. his result is surpris-
ing because vector control is expected to have a greater 
impact on P. falciparum than P. vivax, due in part to the 
longer extrinsic incubation period for P. falciparum and 
the role of dormant hypnozoites in P. vivax transmission. 
hese higher infection rates in year 3 may be inluenced 
by low mosquito numbers and further work to determine 
long-term trends is needed.
Conclusions
his study has demonstrated a strong community impact 
of LLINs on exophagic and early biting vector popula-
tions. Success may be attributable to high LLIN owner-
ship as well as a portion of the vector population that 
continues host seeking during the time when people are 
indoors. Individual malaria exposure will be afected 
by house construction, personal bed net use and other 
human behavioural patterns. Although LLINs had a clear 
impact on vector populations, the impact on sporozoite 
prevalence did not extend to year 3. Given the plasticity 
of mosquito behaviour and natural luctuations in vector 
densities, continued surveillance is needed to determine 
changes in the efectiveness of LLINs.
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Mosquito Behavior Change Ater Distribution of Bednets 
Results in Decreased Protection Against Malaria Exposure
Edward K. Thomsen,1 Gussy Koimbu,2 Justin Pulford,1 Sharon Jamea-Maiasa,3 Yangta Ura,3 John B. Keven,4 Peter M. Siba,3 Ivo Mueller,5  
Manuel W. Hetzel,6,7 and Lisa J. Reimer1
1Liverpool School of Tropical Medicine, United Kingdom; 2Papua New Guinea Institute of Medical Research, Madang; 3Papua New Guinea Institute of Medical Research, Goroka; 
4Michigan State University, East Lansing; 5Walter and Eliza Hall Institute, Parkville, Victoria, Australia; 6Swiss Tropical and Public Health Institute, Basel, Switzerland; and 7University 
of Basel, Switzerland
Background. Behavioral resilience in mosquitoes poses a signiicant challenge to mosquito control. Although behavior changes 
in anopheline vectors have been reported over the last decade, there are no empirical data to suggest they compromise the eicacy of 
vector control in reducing malaria transmission.
Methods. In this study, we quantiied human exposure to both bites and infective bites of a major malaria vector in Papua New 
Guinea over the course of 4 years surrounding nationwide bednet distribution. We also quantiied malaria infection prevalence in 
the human population during the same time period.
Results. We observed a shit in mosquito biting to earlier hours of the evening, before individuals are indoors and protected by 
bednets, followed by a return to preintervention biting rates. As a result, net users and non–net users experienced higher levels of 
transmission than before the intervention. he personal protection provided by a bednet decreased over the study period and was 
lowest in the adult population, who may be an important reservoir for transmission. Malaria prevalence decreased in only 1 of 3 
study villages ater the distribution.
Discussion. his study highlights the necessity of validating and deploying vector control measures targeting outdoor exposure 
to control and eliminate malaria.
Keywords.  Infectious Disease Vectors; Mosquito Control; Mosquito behavior; Insecticide-Treated Bednets; Malaria.
In the past 2 decades, global eforts to reduce the burden 
of malaria have intensiied. Since 2000, the primary strat-
egy to limit transmission has been the distribution of insecti-
cide-treated bednets (ITNs). Recent estimates suggest that in 
the last 15 years, ITNs have been responsible for preventing 68% 
of the 663 million cases that have been averted in sub–Saharan 
Africa due to increased malaria control eforts [1]. However, it 
is well recognized that strategies solely targeting endophagic, 
anthropophagic, and endophilic vectors may not be suicient to 
control and eliminate malaria [2]. his is particularly true out-
side Africa where vectors exhibit greater behavioral plasticity. 
Control eforts can result in shits in vector behavior and/or spe-
cies composition such that the post-intervention vector commu-
nity is less likely to come in contact with insecticide [3–9].
Studies to accurately quantify exposure to bites and the true 
protective eicacy of long-lasting insecticidal nets (LLINs) [10] 
have revealed that the vast majority of exposure still occurs inside, 
when people can be protected by an LLIN [11]. hus, despite 
shits to outdoor feeding [4, 5, 12] and changes in biting times 
[13], the personal protection provided by LLINs remains high 
(>80%). In areas outside of sub–Saharan Africa where vectors bite 
earlier and outside, LLINs can still reduce transmission through 
the combined efect of frequent blood-feeding and a homogenous 
host-seeking phenotype [14, 15]. Regardless, in some settings, evi-
dence suggests that these behavioral changes are decreasing the 
personal protection against bites ofered by an LLIN [16], a wor-
rying prospect for malaria control and elimination in these areas.
It is well established that residual malaria transmission 
(transmission that remains despite universal coverage of efec-
tive interventions [2]), can be intense. However, it is currently 
unknown whether the interventions that are deployed against 
malaria vectors have the ability to increase residual transmis-
sion intensity through shits in behavior or how shits in behav-
ior may impact human infection prevalence. Modeling suggests 
that the presence of behavioral resistance could dramatically 
increase transmission, perhaps more so than physiologi-
cal resistance [8], which is currently poised to create a public 
health disaster if not confronted immediately. Behavioral resis-
tance could have catastrophic consequences for the sustainabil-
ity of currently available vector control methods, especially in 
areas outside of sub–Saharan Africa characterized by outdoor 
transmission [17, 18]. In this study, we estimate the exposure 
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to infective bites experienced by children and adults in Papua 
New Guinea (PNG) before and ater a nationwide LLIN distri-
bution. In addition, we quantiied malaria infection prevalence 
in the mosquito and human populations. We show that follow-
ing the intervention, there was a shit in the biting behavior of 
the major malaria vector, Anopheles farauti 4. his caused the 
protective eicacy of LLINs to decrease, and the ability of nets 
to control malaria in this situation was compromised.
METHODS
Mosquito Collection
Longitudinal monitoring of mosquito abundance was performed 
by outdoor human landing catch in Kokoine (−5.69029, 145.4801) 
and Mauno (−5.65079, 145.493) villages in Madang Province of 
PNG. hese villages sit 4.6 km apart in the Ramu River valley. 
Trained collectors sat outside a house with their pant legs rolled 
up. hey collected host-seeking mosquitoes that landed on their 
legs with an aspirator, and stored all captured mosquitoes in cups 
according to hour of collection. One collector worked from 6 pm 
to 12 am, and another worked from 12 am to 6 am. he collec-
tors switched shits on sequential collection nights. Two houses 
were sampled each night, and collections were performed for 6 
consecutive nights. he irst collections in both villages occurred 
in December 2008, 1  month before LLINs were distributed in 
January 2009 [19]. Subsequent collections occurred in November 
of 2009 and September of 2010. In 2011, collections were per-
formed in March, July, and November, but no signiicant seasonal 
variation was observed in either village (in both mean biting rates 
and infection rates), so results from these 3 months were pooled 
in subsequent analyses. he species of mosquito was conirmed 
by polymerase chain reaction–restriction fragment length poly-
morphism of the ITS2 region [20] using either an individual leg 
or extracted DNA. Lysates from whole mosquitoes were screened 
for Plasmodium falciparum, Plasmodium vivax 210, and P. vivax 
247 circumsporozoite proteins by enzyme-linked immunosor-
bent assay [21] in pools of 5 mosquitoes each.
To estimate the proportion of bites experienced inside and 
outside, additional collections were performed in June 2011. 
During this month, indoor landing catches were performed 
simultaneously with the outdoor landing catches at 1 chosen 
household per night for 6 consecutive nights. he degree of 
endophagy is presented as the proportion of mosquitoes col-
lected by indoor landing catches out of the paired total.
Human Behavior
Human movement inside and outside was quantiied as part 
of a national household survey and questionnaire [22]. Heads 
of household were asked what time individuals in the house 
went inside, what time they went to bed, and how old they 
were. Kokoine and Mauno were not included as part of this 
household survey, but data concerning human movement were 
similar across the lowland regions of the country. herefore, 
patterns of movement and bed times in the Momase region 
were used in this analysis.
Human Infection Prevalence
Human infection prevalence was measured in February and 
March of 2008, 2009, and 2011 in Mauno, Kokoine, and 
Kesowai (−5.79683, 145.62299) villages. he methods used in 
this household survey have already been described [19]. Briely, 
a inger prick blood sample was taken from consenting individ-
uals aged >5 months old from 30–35 randomly selected house-
holds in each village. Stained blood slides were double-read by 
trained microscopists at the PNG Institute of Medical Research.
Data Analysis
Nightly biting rates were compared between years using a 1-way 
analysis of variance and Tukey’s test for post-hoc comparisons. 
Median biting times, 1st and 3rd quartiles, and 95% conidence 
intervals were calculated based on the entire catch per village 
and year. Kruskal–Wallis tests with pairwise comparisons were 
performed to determine whether the distribution of biting 
times between years was the same. Sporozoite prevalence was 
calculated as minimum prevalence, where positive pools were 
assumed to only have 1 positive mosquito. Prevalence for each 
year was calculated by dividing the total number of positive 
pools (with either P. falciparum or P. vivax) by the total number 
of mosquitoes in all pools analyzed. Prevalence was compared 
between years with chi-square tests. At 10 pm, 90% of individu-
als were inside, so this time point was chosen to compare spo-
rozoite prevalence in early biting mosquitoes using a chi-square 
test. Four indices of exposure and protection were estimated: 
exposure to bites (either for a net user [B
p
] or a non–net user 
[B
u
]), the proportion of exposure occurring indoors (π
i
), the 
true protection against mosquito bites (P*), and the true pro-
tection against infective bites (P*f). Estimates of exposure to 
bites for net users and nonusers were calculated as published 
previously [10] with 2 modiications. First, because paired 
indoor and outdoor landing catches were not performed during 
the entire study period, indoor hourly biting rates were esti-
mated by irst calculating the hourly proportions biting inside 
and outside during the paired collections. Hourly proportions 
were then multiplied by hourly outdoor biting rates to estimate 
hourly indoor biting rates. Second, estimates of indoor expo-
sure for net users was reined by accounting for the period ater 
individuals moved inside and before they went to bed. he esti-
mate of exposure for a net user (B
p
) was therefore:
B B I B I S B S PP
t
o t t i t t t i t t= −( ) + −( ) + −( ) 
=
∑
1
24
1 1
, , ,
,
where B
o,t
 is the outdoor biting rate at time t, I
t
 is the proportion 
of individuals inside at time t, B
i,t
 is the indoor biting rate at 
time t, S
t
 is the proportion of individuals sleeping at time t, and 
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P is the protection provided by nets, which is assumed to be 
0.968 [23]. Similar modiications were made to the calculation 
of B
u
, P*, and π
i
.
Exposure to infective bites was estimated by irst calculating 
the hourly infection rate N
t
. Exposure to infective bites for a 
net-user was therefore
F B Np
t
p t t=
=
∑
1
24
,
,
and for a non-user
F B Nu
t
u t t=
=
∑
1
24
,
.
he personal protection against infective bites (P*f) provided by 
an LLIN was
P
F
F
f p
u
*
.= −1
B
u
 was compared across years in each village using Kruskal–
Wallis tests with pairwise comparisons. π
i
 and P* were com-
pared among age groups and years using generalized linear 
mixed models with a binomial distribution, village as a sub-
ject, year by age group as the ixed efect, and household nested 
within date as a random efect. For each dependent variable, a 
dataset was constructed using the formulas described herein (or 
derivatives of) to estimate exposure values for each household 
and date combination. All statistical analyses were performed 
with SPSS 22.
Prevalence of malaria positivity was compared between years 
within each village using chi-square tests.
Ethical Approval and Informed Consent
Informed consent was obtained from all participants or their 
parent/guardian for those aged <16  years. his study was 
approved by the institutional review board at the Papua New 
Guinea Institute of Medical Research (protocol 0933) and the 
Medical Research Advisory Council of PNG (protocol 10.12).
Results
Biting Rates
Over the course of 4  years (2008–2011), 41 757 anopheline 
mosquitoes were captured by 138 outdoor human landing catch 
collections. More than 99% (n = 41 407) were identiied as An. 
farauti sensu lato. he remaining mosquitoes were identiied as 
An. koliensis (n  =  157), An. punctulatus (n  =  122), An. longi-
rostris (n = 69), and An. karwari (n = 2). All 4267 of the An. 
farauti s.l. mosquitoes that were conirmed by polymerase chain 
reaction were An. farauti 4. he nightly biting rate signiicantly 
decreased 1 year ater LLINs were distributed in both villages 
(from 560 to 212 bites/person/night in Kokoine, P  =  .001; 
and from 156 to 37 bites/person/night in Mauno, P < .001). In 
Kokoine, nightly biting rates increased signiicantly in 2010 (to 
374 bites/person/night) and remained at that level in 2011 (418 
bites/person/night). In Mauno, nightly biting rates remained 
low but did increase signiicantly between 2010 (4 bites/person/
night) and 2011 (66 bites/person/night, P < .001).
Host-Seeking Behavior
he median outdoor biting time in both villages occurred signii-
cantly earlier ater the distribution of LLINs (Figure 1A and 1B). 
In Kokoine, the median biting time was 11 pm–12am in 2008 
and was 1 hour earlier in 2009. Although the value of median bit-
ing time returned to 11 pm–12am in 2010–2011, there was still a 
signiicant shit from the preintervention value due to the change 
in bite time distribution, with more mosquitoes biting earlier 
than the median time ater LLIN distribution. In Mauno, the 
median biting time was 12 pm–1 am in 2008, and shited 2 hours 
earlier (10 pm –11 pm) in 2009. In 2010 and 2011, the median 
biting time remained at 10 pm–11 pm, but the distribution of bites 
continued to shit even earlier. In both villages, the hour of maxi-
mum biting density was 10 pm–11 pm in 2008, and 8 pm–9 pm in 
2011 (Figure 1C and 1D). he degree of endophagy remained rel-
atively consistent throughout the hours of the night, with 16.5% 
of overall bites occurring inside (Supplementary Figure 1).
Mosquito Infection Prevalence
Sporozoite prevalence remained consistent across all 4  years 
in Mauno but increased signiicantly in 2011 in Kokoine 
(Figure 2). Mosquito infection prevalence ranged from 0% to 
0.54% in Kokoine and 0% to 0.42% in Mauno. he propor-
tion of infective bites occurring before 10 pm was not diferent 
between years.
Human Sleeping Behavior
Movement of people indoors occurred slightly earlier in the 
highland than in the lowland regions of PNG. Sleeping pat-
terns were similar across the 4 main geographical regions 
(Supplementary Figure 2).
In Momase, where Kokoine and Mauno are located, data 
were disaggregated by sex and age. Adolescent and adult males 
had later patterns of activity than females, and younger indi-
viduals went inside and went to bed earlier than older individ-
uals (Figure 3A and 3B). he proportion of individuals sleeping 
under an LLIN did not exceed 0.71 among any age group at any 
time of night, with males aged 15–19 years the least protected 
at 0.54 (Figure 3C). A separate study in this village reported 
net usage at 91% in 2012 (J. Keven, L. Reimer, M. Katusele, 
G. Koimbu, R. Vinit, N. Vincent, E. homsen, D. Foran, P. 
Zimmerman, and E. Walker, submitted).
Exposure
Ater a signiicant decrease in exposure between 2008 and 
2009 in both villages (P  <  .001 for Kokoine and Mauno), 
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there was subsequently a signiicant increase from 2009 to 
2011 in Kokoine and from 2010 to 2011 in Mauno (Figure 4). 
Shits to earlier bite exposure were observed in both villages 
(Supplementary Figure  3). Within each year, the estimated 
proportion of exposure occurring inside (π
i
) and the protective 
eicacy against bites (P*) was signiicantly greater in younger 
age groups (P < .001 for all years). Within each age group, there 
was a decrease in π
i
 and P* ater LLINs were distributed, and 
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Figure 2. Sporozoite prevalence for Plasmodium falciparum and Plasmodium vivax in An. farauti 4 in Kokoine (A) and Mauno (B) villages of Papua New Guinea before 
(2008) and after (2009–2011) a long-lasting insecticidal net distribution. Sample sizes are indicated below each year. Bars not sharing the same letter indicate signiicant 
differences using chi-square tests.
Figure 1. Median outdoor biting times with 1st and 3rd quartiles (boxes) and 95th percentiles (whiskers) in Kokoine (A) and Mauno (B) villages of Papua New Guinea before 
(2008) and after (2009–2011) a long-lasting insecticidal net distribution. Years not sharing the same letter indicate signiicantly different medians using a Kruskal–Wallis test 
with pairwise comparisons. The proportion of bites occurring at each hour in Kokoine (C) and Mauno (D) are presented as well.
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the decrease was more pronounced in younger age groups 
(Figure 5; for π
i
: <5, P <  .001; 5–9, P =  .002; 10–14, P =  .004; 
15–19, P  =  .008; >20, P  =  .03; and for P*: <5, P  =  .001; 5–9, 
P = .003; 10–14, P = .006; 15–19, P = .01; >20, P = .02).
In Kokoine, the rebound in biting rates coupled with high 
sporozoite prevalence ater LLIN distribution (in 2011) allowed 
us to quantify exposure to infective bites (Figure  6). In 2008, 
most exposure to infective bites occurred ater 9 pm. In 2011, 
the majority of infective bites occurred during the irst hour of 
collection, between 6 pm and 7 pm. In children aged <5 years, 
many infective bites would have been prevented by using a net 
in 2008; however, the protective eicacy of LLINs against infec-
tive bites (P*f) decreased drastically in 2011 because these bites 
were occurring before this age group went to bed. In adults aged 
>20  years, a similar but less pronounced decrease in P*f was 
observed, primarily because this age group was always outside 
when infective mosquitoes were seeking a host. In 2008, P*f was 
0.78 in those aged <5 years and 0.30 in those aged >20 years. 
In 2011, P*f had decreased to 0.30 and 0.15 in both groups, 
respectively.
Human Infection Prevalence
Data from the 2008 and 2009 malaria prevalence surveys have 
been published elsewhere [19] and are presented in greater 
detail here for context. Only Mauno showed a consistent and 
signiicant decrease in malaria prevalence across the 3 surveys. 
In Kokoine, there was no signiicant change in overall infec-
tion prevalence, and in Kesowai there was a nearly signiicant 
increase in prevalence from 2008 to 2011 (P = .058) (Figure 7).
DISCUSSION
Our data show a clear and dramatic reduction in mosquito abun-
dance in the irst year ater the LLIN distribution in both villages. 
However, a resurgence in mosquito abundance and exposure was 
documented between 2 and 3 years ater intervention, coupled 
with a shit to signiicantly earlier biting. Based on the interaction 
between mosquito and human behavior, the protective eicacy 
of LLINs decreased during this resurgence, as more exposure to 
malaria vectors occurred before individuals were protected with 
a net. Besides behavioral resilience [24], 2 other factors may have 
contributed to the documented resurgence in mosquito abun-
dance. First, physiological resistance to insecticides has also been 
shown to reduce intervention eicacy [25]. However, resistance 
is absent in members of the An. punctulatus group (the species 
group to which An. farauti 4 belongs) in PNG [26], and suscep-
tibility has been conirmed from the Sausi region post-LLIN 
distribution (M. Katusele, unpublished data). his demonstrates 
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Figure 3. Proportion of males (M) and females (F) from each age group inside (A), 
in bed (B), and in bed under a long-lasting insecticidal net (LLIN) (C) from 6 PM to 6 AM.
Figure 4. Total estimated exposure to bites for a non–net user before bednets 
(2008) and after bednets (2009–2011) in Kokoine and Mauno. Years sharing the 
same letters were not statistically different using a Kruskal–Wallis test with pair-
wise comparisons.
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that behavioral resilience may compromise intervention eicacy 
in a mosquito population that is fully susceptible to insecticide. 
Second, changes in bednet usage over time could limit the com-
munity efect of nets; however, usage increased over the study 
period. Furthermore, used nets from local communities retain 
the insecticidal efect against An. farauti for 5 years [27].
his is the irst study to quantify human malaria infec-
tion prevalence in the context of shiting mosquito behaviors 
ater an LLIN distribution. Malaria prevalence in humans 
decreased in only 1 of 3 villages, the village with the lowest 
biting rates, demonstrating the limited eicacy of nets to pre-
vent disease transmission. Although the shits in biting times 
would contribute to the limited epidemiological impact of the 
intervention, there are other factors that may have also played 
a role. Artemisinin combination therapy was only rolled out 
to the Sausi health center in the last quarter of 2011, which 
means that the population may have been receiving inade-
quate treatment. Treatment failures with the previous com-
bination of chloroquine and sulphadoxine-pyrimethamine 
reached 18.5% in children with P. falciparum in PNG [28]. 
Migration of individuals into the study communities from 
areas of higher malaria burden may have also been a factor. 
Regardless, shits in biting times have been documented in 
other mosquito populations in PNG [9]. As such, it will be 
important to continually monitor the epidemiological impact 
of LLINs in other areas where changes in mosquito behavior 
have been observed.
his is also the irst study to quantify age-stratiied exposure to 
bites of malaria vectors by taking into account the behaviors and 
sleeping patterns of each age group. Both the proportion of indoor 
bite exposure (π
i
) and the protective eicacy of LLINs against bites 
(P*) is greater in younger age groups, due to earlier sleeping pat-
terns. his results in protection by an LLIN for a greater propor-
tion of the entire period of exposure, which is a positive inding 
because this group is the most at risk for severe disease [29]. In 
contrast, the protective eicacy in adults is quite low (approxi-
mately 0.35 in both villages at the time of distribution) due to their 
greater outdoor activity patterns in the early hours of the night. 
Adults will continue to act as a reservoir of gametocytes, and 
LLINs may therefore have little impact on transmission reduction 
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Figure  6. Estimated exposure to infective bites in children aged <5  years (A) 
and adults aged >20 years (B) in Kokoine. Exposure was estimated separately for 
bednet users and nonusers at the time of the distribution (2008) and 3 years later.
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at the community level. his level of personal protection against 
bites is similar to that seen in other areas of the South Paciic [16].
he true protective eicacy of nets (against bites [P*] and 
infective bites [P*f]) decreased in both villages ater LLINs were 
distributed. he reduced eicacy due to shits in host-seeking 
times is a phenomenon that has been observed in other stud-
ies. In An. funestus, a shit to early morning feeding in south-
ern Benin did not result in compromised eicacy because P* 
remained >80% [13]. In An. farauti s.s., a shit to early evening 
feeding in the Solomon Islands did reduce P* [16]. However, 
individual mosquitoes showed no idelity to biting time or 
location, and malaria burden continued to decline [14]. he 
authors hypothesized that over the course of several gonotrop-
hic cycles, the likelihood of exposure to an LLIN before the end 
of the Plasmodium extrinsic incubation period still remained 
high [15]. Unlike the studies described above, our study sug-
gests that the shit to early evening feeding in An. farauti 4 is 
epidemiologically signiicant—the estimate of the annual ento-
mological inoculation rate in Kokoine was 827 infective bites 
per person per year in 2011, more than double the estimate of 
343 in 2008. In addition, our analysis indicated that individuals 
were less protected from infective bites in 2011 than they would 
have been in 2008 due to the time infective mosquitoes were 
collected.
he underlying mechanism for the shit in biting times 
observed in this vector population is currently unknown. 
Biting behavior in anophelines appears to be a heritable trait 
because shits in host-seeking behavior in the Solomon Islands 
during the dichlorodiphenyltrichloroethane spray campaign 
of the 1970s [3] remain to this day [16]. However, additional 
evidence for population-level selection for behavioral resis-
tance is lacking [7]. Today, populations of An. farauti s.s. in the 
Solomon Islands are homogenous in their host-seeking behav-
ior: subpopulations exhibiting diferent feeding preferences 
do not exist [14]. In addition, the genes responsible for the 
variation in feeding behaviors in malaria vectors have yet to 
be identiied [30]. Additional hypotheses for the mechanism 
include associative learning [24] and delayed host-seeking due 
to unsuccessful attempts the previous night [31].
he sampling scheme used in this study had several limita-
tions. First, human landing catches were not performed before 
6 pm. his may have resulted in signiicant undersampling of 
the biting population ater LLIN distribution. Second, the ratio 
of indoor to outdoor biting rates was measured during 1 collec-
tion period ater LLIN distribution. he high degree of exoph-
agy measured here is consistent with reports of An. farauti 4 in 
neighboring Papua, Indonesia [18], as well as other members of 
the An. farauti complex in the Solomon Islands [32]. Decreases 
in endophagy have been observed following indoor interven-
tions [3, 4], which we are unable to capture in our study design. 
If early biting mosquitoes were undersampled or if the popula-
tion experienced a shit in endophagy, the analysis would have 
underestimated the decreases in personal protection. hird, 
collections were performed in 2 weeks in 2008, 2009, and 2010 
and 6 weeks in 2011, which may have highlighted week-to-week 
variation and obscured long-term trends.
Indoor interventions such as LLINs have contributed greatly 
to the reduction in malaria transmission over the last 15 years 
[1] and continue to provide signiicant community protection 
even in cases where shits in biting behavior have been observed 
[6, 11, 12, 14, 15]. Our study highlights that in an area of high 
vector density and intense year-round transmission, shits in 
biting behavior can have detrimental impacts on the personal 
protection provided by LLINs as well as community-wide 
transmission. Shits to earlier biting ater the bednet distribu-
tion resulted in greater exposure to infective bites, in net users 
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Figure  7. Human infection prevalence as detected by microscopy in Kokoine 
(A), Mauno (B), and Kesowai (C) villages before (2008) and after (2009 and 2011) a 
nationwide LLIN distribution in PNG. * indicates a signiicant change from 2008 
(P < .05) using a chi-square test.
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and nonusers alike. he intervention achieved a reduction in 
malaria prevalence in only 1 of 3 villages studied despite high 
usage rates and net eicacy. Additional tools targeting outdoor 
and early biting mosquitoes will be necessary to control malaria 
and prevent a resurgence of transmission.
Supplementary Data
Supplementary materials are available at he Journal of Infectious Diseases 
online. Consisting of data provided by the authors to beneit the reader, the 
posted materials are not copyedited and are the sole responsibility of the 
authors, so questions or comments should be addressed to the correspond-
ing author.
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Efﬁcacy, Safety, and Pharmacokinetics of Coadministered
Diethylcarbamazine, Albendazole, and Ivermectin for
Treatment of Bancroftian Filariasis
Edward K. Thomsen,1,2,a Nelly Sanuku,1 Manasseh Baea,1 Samson Satofan,1 Elit Maki,1 Bart Lombore,1 Mark S. Schmidt,3 Peter M. Siba,1
Gary J. Weil,4 James W. Kazura,2 Lawrence L. Fleckenstein,3 and Christopher L. King2,5
1Papua New Guinea Institute of Medical Research, Papua New Guinea; 2Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio; 3Department of
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Background. Available treatments for lymphatic ﬁlariasis (LF) are limited in their longterm clearance of microﬁlaria from the
blood. The safety and efﬁcacy of a single-dose triple-drug therapy of the antiﬁlarial drugs diethylcarbamazine (DEC), ivermectin
(IVM), and albendazole (ALB) for LF are unknown.
Methods. We performed a pilot study to test the efﬁcacy, safety, and pharmacokinetics of single-dose DEC, IVM, and ALB in
Wuchereria bancrofti-infected Papua New Guineans. Adults were randomized into 2 treatment arms, DEC 6 mg/kg + ALB 400 mg
(N = 12) or DEC 6 mg/kg + ALB 400 mg + IVM 200 μg/kg (N = 12), and monitored for microﬁlaria, parasite antigenemia, adverse
events (AEs), and serum drug levels.
Results. Triple-drug therapy induced >2-log reductions in microﬁlaria levels at 36 and 168 hours after treatment compared with
approximately 1-log reduction with 2 drugs. All 12 individuals who received 3 drugs were microﬁlaria negative 1 year after treatment,
whereas 11 of 12 individuals in the 2-drug regimen were microﬁlaria positive. In 6 participants followed 2 years after treatment, those
who received 3 drugs remained microﬁlaria negative. AEs, particularly fever, myalgias, pruritus, and proteinuria/hematuria, occurred
in 83% vs 50% of those receiving triple-drug compared to 2-drug treatment respectively (P = .021); all resolved within 7 days after
treatment. No serious AEs were observed in either group. There was no signiﬁcant effect of IVM on DEC or ALB drug levels.
Conclusions. Triple-drug therapy is safe and more effective than DEC + ALB for Bancroftian ﬁlariasis and has the potential to
accelerate elimination of lymphatic ﬁlariasis.
Clinical Trials Registration. NCT01975441.
Keywords. lymphatic ﬁlariasis; chemotherapy; diethylcarbamazine; albendazole; ivermectin.
Wuchereria bancrofti is a mosquito-transmitted, chronically
disabling nematode infection that causes lymphedema, ele-
phantiasis, and hydroceles. Wuchereria bancrofti is endemic
in 73 countries, infecting approximately 100 million people
[1]. The World Health Organization has targeted lymphatic ﬁl-
ariasis (LF) for global elimination by 2020 [2]. Since there is no
drug that reliably kills or sterilizes adult ﬁlarial worms, the focus
of the Global Programme to Eliminate Lymphatic Filariasis
(GPELF) has been on the use of mass drug administration
(MDA) to reduce the source of microﬁlaria in endemic popula-
tions and thereby interrupt transmission. The current MDA
strategy is to provide repeated, annual doses of albendazole
(ALB) with either diethylcarbamazine (DEC) or ivermectin
(IVM) for the lifespan of adult worms (typically 5–7 years)
[3]. Mathematical models of LF transmission suggest that the
most potent drug combination currently recommended (annual
DEC + ALB) will require high compliance (>70%) with MDA
for 5–7 years in order to achieve elimination targets, particular-
ly in areas with moderate to high endemicity [4]. Clinical trials
have shown that a single dose of this combination clears micro-
ﬁlaria in only approximately 25% of participants at 12 months
[5–8]. Drug regimens with better activity against microﬁlaria
would prevent new infections that would otherwise have to be
treated in later years. This could signiﬁcantly improve the
chances for eliminating LF in resource poor settings.
Addition of the potent microﬁlaricide IVM to DEC +
ALB may improve microﬁlaria clearance and provide a more
long-lasting effect than the widely used 2-drug regimen [7–
9]. Prior community studies have shown that MDA with
IVM plus DEC was more effective for reducing microﬁlaria
rates than DEC alone [10]. A single dose of IVM completely
cleared microﬁlaria in 35% of participants and reduced the
geometric mean microﬁlaria level by >98% at 1 year; 2 years
after a single treatment, 20% of participants remained micro-
ﬁlaria negative, and geometric mean microﬁlaria levels
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remained reduced by >90% [11]. Similar but less profound ef-
fects were observed for single-dose IVM in a trial conducted in
Tanzania [12]. It is possible that simultaneous treatment with
IVM + DEC + ALB could reduce the number of rounds of
MDA required to reach LF elimination, and this could have
a transformative impact on the 60% of LF-exposed popula-
tions that reside outside of sub-Saharan Africa.
Since the tolerability and potential drug interactions of this
3-drug combination have never been investigated, we under-
took a pilot study to compare the safety, tolerability, pharmaco-
kinetics, and efﬁcacy of IVM + DEC + ALB vs DEC + ALB in
individuals with Bancroftian ﬁlariasis.
METHODS
Study Location
Participants were recruited from the villages of Tau 1 and 2
(3.6718 S,142.7254 E), Dreikikir District, in East Sepik Province,
Papua NewGuinea, withmicroﬁlaria rates of 10%–44%. No prior
treatment for LF has ever been given in these 2 communities. All
participants where hospitalized at the Dreikikir Health Center for
the initial days following treatment.
Selection of Study Participants and Study Design
Study inclusion and exclusion criteria were as follows: aged
18–60 years, >100 microﬁlaria /mL, no prior antiﬁlarial medica-
tions, or free from any acute or chronic illnesses. If inclusion
and exclusion criteria were fulﬁlled, enrolled individuals had a
1-mL venous night blood sample (after 2200 hours) and serum
biochemistries measured to ensure that alanine transaminase
(ALT), aspartate transaminase (AST), and creatinine were
<1.5 times normal; hemoglobin levels were >7 gm/dL; and
there was no signiﬁcant urine proteinuria, hematuria, or gluco-
suria by dipstick measurement 1 to 2 weeks prior to hospitali-
zation (Figure 1). A total of 903 individuals were prescreened,
53 were enrolled, and 24 met the ﬁnal inclusion and exclusion
Figure 1. Study design. Abbreviations: ALB, albendazole; ALT, alanine transaminase; AST, aspartate transaminase; BP, blood pressure; Cr, creatinine; DEC, diethylcarbamazine;
F, female; Hgb, hemoglobin; hx, history; IV, intravenous; IVM, ivermectin; LF, lymphatic filariasis; M, male; mf, microfilaria; NL, normal; PE, physical examination; U/A, urinanalysis.
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criteria and agreed to participate in the study. One individual
withdrew 72 hours after treatment and 2 individuals failed to
return on day 7 but did have blood drawn 1 year later. Eleven
individuals were unavailable at the 2-year follow-up (Figure 1).
This was a single-blinded, parallel-group, randomized study
with 2 treatment arms. Participants were stratiﬁed by sex and
randomly assigned to 1 of 2 treatment groups: DEC 6 mg/kg -
+ ALB 400 mg or DEC 6 mg/kg + IVM 200 μg/kg + ALB 400
mg. A blood sample was taken to establish baseline ALT, AST,
and creatinine levels immediately prior to treatment. Partici-
pants were given a breakfast of peanut butter and biscuits
prior to observed administration of drugs. Blood draws were
performed at 0, 1, 2, 3, 4, 6, 8, 12, 24, 36, 48, and 72 hours
and 7 days following experimental drug treatment (Figure 1).
Parasitological, Biochemical, and Drug Testing
Parasitemia levels were assessed by passing 1 mL of anticoagu-
lated, nocturnally collected blood through a 5-µm polycarbonate
ﬁlter (EMD Millipore Corp., Billerica, Massachusetts), washed
with ﬁltered water, placed on glass slides, dried, and stained
with Giemsa. Microﬁlariae were counted by microscopy. Antigen
levels were measured using the Og4C3 mAb–based assay [13].
Plasma for drug levels was stored at −80°C. Evaluation of AST,
ALT, and creatinine levels was performed using a Vitros DT-60
II biochemistry analyzer (Ortho Clinical Diagnostics, Rochester,
New York). Glucose, blood, protein, nitrites, and leukocytes were
measured with a urine dipstick (Multistix 10 SG, Bayer/Seimens,
Malvern, Pennsylvania), with severity graded according to the
manufacturer’s protocol. Hemoglobin levels were evaluated on a
HemoCue Hb 201+machine (HemoCue Inc. Cypress, California).
All pharmacokinetic analyses were performed at the Univer-
sity of Iowa’s College of Pharmacy. The concentration of DEC
was determined using high-performance liquid chromatogra-
phy with mass spectrometric detection [14]. IVM concentra-
tions were determined using a previously published extraction
methodology [15]. The linear range of the calibration curve was
0.20–400 ng/mL from 0.20 mL plasma.
Clinical Evaluation and Adverse Events Recording
The night prior to drug dosing, a thorough clinical assessment was
performed. Circumference of all limbs was recorded at each time
point. Scrotal abnormalities were classiﬁed as edema, hernia, or hy-
drocele, and any hydroceles graded as smaller or larger than a ﬁst.
Objective adverse events (AEs) were based on serial physical
examinations, biochemical evaluations, and urinalysis every 4
hours for the ﬁrst 12 hours then at 24, 48, and 72 hours and
7 days after treatment (Figure 1). AEs were deﬁned as any
one of the following: any increase in ALT, AST, or creatinine
measurement >1.5 times the upper limit of the reference
range; tympanic temperature >37.8°C; increase in lymph node
tenderness, swelling, or pain from baseline; or increase in pro-
teinuria or hematuria from baseline based on urine dipstick
measurement. A scoring system was used for proteinuria and
hematuria based on severity and duration of the abnormal dip-
stick measurement. First hematuria (or proteinuria) was scored
as negative (0), mild (1+), moderate (2+), and severe (3+) with a
negative assigned a score of 0, mild a score of 1, moderate a
score of 2, and severe a score of 3. If an abnormal urine dipstick
measurement was observed on just 1 testing day post-treatment
(eg, at 24, 48, and 72 hours and day 7 post-treatment), a score of
1 was given. If the urine dipstick measurement remained abnor-
mal for 2 days, a score of 2 was given to a maximum of 4 if the
urinalysis remained abnormal for the 4 testing time points. A
ﬁnal score for each treatment group was determined by adding
the sum of all these values for the12 individuals in each group.
Subjective AEs were assessed by asking participants about
symptoms that they may have experienced after taking the med-
ication that either increased in severity or was experienced for
the ﬁrst time following treatment. Participants were asked to
categorize any symptoms as mild (does not interfere with
daily activity), moderate (interferes with daily activity), or severe
(warrants hospital admission).
Informed Consent and Regulatory Monitoring
Institutional review boards at the University Hospitals Case
Medical Center, Cleveland, Ohio, the Papua New Guinea Insti-
tute of Medical Research, and the Medical Research Advisory
Committee of Papua New Guinea approved study protocols
and documents. The trial was registered at ClinicalTrials.gov
(NCT01975441).
Data Treatment and Analyses
The study was powered to look at drug interactions and AEs, with
changes in microﬁlaria levels as a secondary outcome. Objective
and subjective AEs were compared separately using Mann–
Whitney–Wilcoxon rank sum test. Differences in microﬁlaremia
levels were assessed using student t test of log-transformed data. A
general linear model was used to examine the independent effects
of treatment and microﬁlaremia levels on the frequency of AEs.
For each participant, pharmacokinetic parameters were esti-
mated by plotting the plasma concentrations (of DEC, ALB, al-
bendazole sulfoxide [ALBSO], albendazole sulfone [ALBSO2],
or IVM) vs time using noncompartmental analysis (WinNonlin
v5.0, Pharsight Corporation, Cary, North Carolina). The maxi-
mumplasma concentration (Cmax) and time ofmaximum concen-
tration (Tmax) were observed directly from the concentration–time
curve. The half-life, area under the curve, and drug–drug interac-
tions were calculated as previously described [14–17] and are
included in the Supplementary Materials.
RESULTS
Population Characteristics and Impact of Treatment on Infection Levels
Before treatment study participants in the 2 treatment groups
had similar infection intensities, age, weight, and hemoglobin
levels (Table 1). A single dose of DEC + ALB + IVM resulted
in almost total elimination of microﬁlaria at 36 hours and 7
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days after treatment, and no participant was microﬁlaremic 12
months after treatment (Figure 2). By contrast, a single dose of
DEC +ALB resulted in less dramatic reductions inmicroﬁlaria lev-
els at 36 hours and 7 days, and 10 of 11 participants remained mi-
croﬁlaremic at the 12-month time point. Twelve participants who
had not moved away and agreed to have an additional night blood
sample drawn (by chance, 6 in each treatment group) were exam-
ined formicroﬁlaria levels 2 years following treatment (Table 2). All
6 individuals who received the single 3-drug treatment remained
amicroﬁlaremic at 2 years (P = .047, compared with those receiving
2 drugs; Table 2). DEC + ALB + IVM also resulted in greater
decreases in ﬁlarial antigen levels compared with DEC + ALB
at 12 months (Figure 3). All participants in both treatment groups
remained antigen positive at 12 months and at 2 years.
Adverse Events Following Treatment
Objective and subjective AEs were mild to moderate in severity
and were experienced by participants in both treatment groups
(Table 3). The ﬁrst AEs started 4 hours after treatment, typically
they were subjective ﬁndings such as nausea and headaches.
These were usually followed by arthralgias and pruritus that
often presented by 8 hours after treatment. Two participants
also developed mild inguinal tenderness at that time. One indi-
vidual developed a fever at 8 hours post-treatment. In other in-
dividuals that developed fevers following treatment, elevated
temperatures were present by 12 hours post-treatment. Temper-
atures often exceeded 39°C and were successfully treated with
acetaminophen. Seven individuals developed hematuria and/
or proteinuria, 3 at 24 hours post-treatment and the remaining
by 48 hours. Hematuria and/or proteinuria resolved by 72 hours
in 3 of 7 individuals, and the remainder resolved by 7 days. Ab-
normal transaminases were conﬁned to AST and followed a
similar kinetics of hematuria and/or proteinuria, with all resolv-
ing by 7 days after treatment.
Overall, 10 of 12 (83%) individuals in the 3-drug treatment
group developed 1 or more objective AEs compared with 6 of
12 (50%, P = .19, Fischer exact test) in the 2-drug group. Median
number of AEs per person in the 3-drug group was 2 compared
Table 1. Population Characteristics and Pretreatment Infection Levels
Treatment Group N
Male/
Female
Geometric Mean
Microfilaremia (microfilaria
/mL) ± 95% CI (range)
Filarial Antigen
(unit/mL)
Geometric
Mean ± 95% CI
Median
Age, y
(range)
Mean
Weight,
kg ± SD
Mean
Hemoglobin,
g/dL ± SD
Diethylcarbamazine + albendazole + ivermectin 12 6/6 1558 ± 2322 (209–13 776) 3881 ± 1227 30 (19–59) 53 ± 9 11.2 ± 1.3
Diethylcarbamazine + albendazole 12 6/6 1857 ± 2191 (133–13 333) 3347 ± 1018 28 (19–50) 49 ± 8 11.0 ± 1.2
Abbreviations: CI, confidence interval; SD, standard deviation.
Figure 2. Percent reduction in microfilaria compared to pretreatment levels at 36 hours, 7 days, and 1 year following treatment with diethylcarbamazine (DEC) + albendazole
(ALB) + ivermectin (IVM) or DEC + ALB. Microfilaria levels were determined by filtering 1 mL of anticoagulated, nocturnally collected peripheral venous blood through a nucle-
opore filter. Significance determined by Student t test.
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with 0.5 in the 1-drug group (P = .094). Hematuria and/or pro-
teinuria also predominantly occurred in the 3-drug treatment
group. A scoring system was used based on severity and dura-
tion of the hematuria and/or proteinuria (see “Methods” sec-
tion), with individuals in the 3-drug group having a score of
16 vs 1 in the 2-drug group.
With respect to subjective AEs, the proportion of individuals
who developed 1 or more complaints, including headache, nau-
sea, pruritus, abdominal pain, weakness, and arthralgia (Table 2),
was similar between the 2 treatment groups (9 of 12 [75%] in
the 3-drug group and 7 of 12 [58%] in the 2-drug group). Indi-
viduals in the 3-drug group tended to have more subjective AEs
(median = 2.5) compared with those in the 2-drug group (medi-
an = 1, P = .091).
When both subjective and objective AEs were combined,
individuals on 3-drug therapy had signiﬁcantly more AEs
(median = 4.5) compared with those receiving 2-drug treatment
(median = 2.5, P = .021). Microﬁlaremia levels prior to treat-
ment (or closely related reduction in microﬁlaria levels at 36
hours) were related to the number of AEs independent of treat-
ment (P = .09).
Drug Interactions and Pharmacokinetics
Drug concentration–time curves are shown in Figure 4 and Sup-
plementary Figure 1. The pharmacokinetic parameter estimates
for DEC, ALB, ALBSO, and ALBO2 with and without IVM ad-
ministration are presented in Supplementary Table 1, along with
parameter estimates for IVM. No signiﬁcant drug interactions
were observed (P > .05 for all treatment group comparisons).
Geometric mean parameter ratios [(with IVM)/(without
IVM)] of Cmax, AUC0–t, and AUC0–∞ for each analyte (DEC,
ALBSO, and ALBSO2) are presented with 90% conﬁdence inter-
vals (CIs) in Supplementary Table 2. DEC Cmax levels in the 2
treatment groups almost met the commonly used limits for no
clinically relevant effect (80%–125%) [17–19].DECAUC0–t and
AUC0–∞ 90% CIs obtained in this study were only slightly out-
side of these limits but were completely within the slightly less
stringent limits of 70%–143%. Ninety percent CIs for the
parameter estimates of ALBSO and ALBSO2 were quite broad,
because of the small samples sizes in this study.
DISCUSSION
In this study, we compared the effects of a new triple-drug
regimen (IVM + DEC + ALB) with standard DEC + ALB as a
Table 2. Microfilarial Levels 2 Years Following a Single Treatment
Treatment
Time Post-Treatment
Pre-Treatment 36 h 7 d 1 y 2 y
Diethylcarbamazine + albendazole 3235a 4 9 10 0
1599 10 8 11 44
1562 1 627 22 0
1095 27 49 7 4
1107 13 1 27 13
1747 87 947 29 37
Diethylcarbamazine + albendazole + ivermectin 689 0 0 0 0
677 1 1 0 0
1034 6 8 0 0
1476 1 4 0 0
1857 0 0 0 0
2509 0 0 0 0
a Microfilaria per milliliter of filtered whole blood.
Figure 3. Percent reduction in serum filarial antigen levels 1 year following treat-
ment compared to levels before treatment in participants receiving a single dose of
diethylcarbamazine (DEC) + albendazole (ALB) + ivermectin (IVM) or DEC + ALB.
Antigen levels were measure using the Og4C3 assay. Significance determined by
Student t test.
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single-dose treatment for Bancroftian ﬁlariasis in treatment-
naive participants with high-intensity W. bancrofti infections.
Triple therapy rapidly eliminated almost all microﬁlaria from
peripheral blood, and, importantly, all participants treated
with this regimen were amicroﬁlaremic 1 and 2 years following
treatment. Microﬁlaria counts also rapidly declined in partici-
pants treated with DEC + ALB but less dramatically than in
those treated with triple therapy. Also, the 2-drug therapy failed
to clear microﬁlaria in most participants 12 and 24 months after
treatment, which is consistent with results from other treatment
trials [7–9, 11]. A greater reduction in circulating antigen levels
with the triple-drug regimen suggests a higher percentage
of adult female worms were killed compared with use of DEC -
+ ALB. Since all treatment participants in both groups had
persistently positive ﬁlarial antigen tests 1 and 2 years after
treatment, neither treatment killed all adults worms [20]. The
absence of microﬁlaria at 1 and 2 years after treatment suggests
the triple-drug therapy had embryostatic and/or embryocidal
effects on adult female worms.
Participants treated with the triple-drug regimen experienced
more AEs than those who received DEC +ALB when both objec-
tive and subjective AEs were combined. All AEs were mild to
moderate in severity, started 8 hours following treatment, peaked
at between 12 and 48 hours, and resolved 7 days later, except in 1
participant who had right inguinal tenderness at day 7. AEs
observed were consistent with the well-documented transient
AEs that have been reported following treatments that kill
microﬁlaria [7–9]. These AEs include fever, headache, pruritus,
arthralgia, tender lymph nodes, and development of proteinuria
and/or hemoglobinuria. The spectrum of AEs was similar in the
Table 3. Number and Frequency of Adverse Events Experienced by Study
Participants After Treatment
Adverse Event
Regimen
Diethylcarbamazine +
Albendazole (N = 12)
Diethylcarbamazine +
Albendazole +
Ivermectin (N = 12)
Objective findings
Fever 2 (17) 6 (50)
Lymphadenitis 5 (42) 3 (25)
Hepatic (alanine
transaminase
\aspartate
transaminase)
abnormalitiesa
2 (17) 1 (8
Proteinuria 1 (8) 3 (25)
Hematuria 0 (0) 4 (33)
Transient low blood
pressure
1 (8) 1 (8)
Subjective findings
Headache 3 (25) 6 (50)
Joint pain 5 (42) 7 (58)
Nausea 1 (8) 3 (25)
Cough 0 (0) 5 (42)
Abdominal pain 1 (8) 4 (33)
Itch 3 (25) 5 (42)
Weakness 0 (0) 2 (17)
Dizziness 2 (17) 1 (8)
a >1.5 times the upper limit of normal.
Figure 4. Mean serum plasma levels (± standard deviation) of (A) diethylcarba-
mazine (DEC), (B) albendazole (ALB) sulfoxide and (C) ivermectin (IVM) at different
times following treatment with DEC + ALB + IVM or DEC + ALB.
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2 treatment arms, except for urinary abnormalities, which were
present almost exclusively in the 3-drug treatment group.
Development of proteinuria and/or hemoglobinuria in urine
ranged from mild to major, as measured by dipstick, and often
persisted for several days. All urine abnormalities resolved by 7
days following treatment. No participant had a signiﬁcant in-
crease in serum creatinine after treatment. Transient urinary
abnormalities were similar to those observed in a previous
study following treatment with DEC alone [21]. The proteinuria
and/or hemoglobinuria may arise from inﬂammation due to
dead microﬁlaria in the kidney. Alternatively, participants may
develop a transient immune complex associated glomerulone-
phritis, as based on prior studies in animal models of ﬁlariasis
[22], renal histology [23–26], and presence of ﬁlariasis-speciﬁc
immune complexes in blood and urine [27] of participants
with LF.
Pharmacokinetic studies were performed to determine wheth-
er IVM affects drug levels or clearance of DEC and ALB. The
absorption and disposition proﬁles of each drug (and/or ALB
metabolites) were not signiﬁcantly different in participants who
received IVM. The pharmacokinetics of DEC and IVMwere sim-
ilar to those seen in previous studies [19, 28, 29]. The pharmaco-
kinetics of ALB in this study was also consistent with that seen in
prior studies that reported that ALB is poorly absorbed and rap-
idly eliminated, primarily through metabolism to ALBSO and
ALBSO2 [19, 28, 29]. The wide variation in ALBSO levels after
ALB is well known and likely due to differences in absorption
of the drug between individuals and differences in ALB metabo-
lism between men and women [30]. There was a clear lack of
signiﬁcant interaction between DEC and IVM. Because of high
interpatient variability in ALBSO exposure parameters, deﬁnitive
conclusions cannot be drawn regarding the lack of an effect of
IVM on ALBSO exposure. However, the point estimates for the
ratios of geometric means are not suggestive of a major inﬂuence
of IVM on ALBSO exposure, and in a previous analysis, Awadzi
et al [28] failed to detect any substantial interaction between these
drugs. Thus, it is unlikely that coadministration of IVM has a
clinically signiﬁcant drug interaction with ALB/ALBSO. It has
historically been assumed that the minor metabolite ALBSO2 is
inactive against ﬁlarial parasites because of its relatively lower
abundance in human serum compared with ALBSO and because
of the known activity of ALB and ALBSO as antagonists of mi-
crotubule formation in nematodes [31]. However, a recent study
reported that ALBSO2 prevents binary ﬁssion in Wolbachia, an
obligate endosymbiont ofW. bancrofti [32]. The present analysis
is the ﬁrst to quantify ALBSO2 pharmacokinetics in patients with
W. bancrofti infection.
This study has shown that single-dose treatment with IVM +
DEC + ALB is safe and more effective for clearing W. bancrofti
microﬁlaria and reducing ﬁlarial antigen levels than standard
treatment with DEC + ALB. Additional studies are needed to
determine the duration of microﬁlaria clearance after IVM +
DEC + ALB and to further establish the safety of this regimen.
A “one and done” regimen could have a transformative impact
on the global program to eliminate LF by reducing the number
of rounds of MDA required to reach elimination targets. This
would be especially useful for countries such as Papua New
Guinea where it is extremely difﬁcult to provide repeated
rounds of MDA to LF-endemic populations, and it could
improve chances for global elimination of LF by the target
year of 2020.
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